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Abstract
Individuals with dementia often exhibit Behavioural and Psychological Symptoms of
Dementia (BPSD). BPSD worsens as dementia progresses and intensifies caregiver distress.
The Registered Nurses’ Association of Ontario recommends non-pharmacologic methods
such as group activities, music therapy, cognitive behavioral therapy, and cognitive
stimulation therapy (CST) to manage BPSD. I wanted to explore the potential of virtual
reality (VR) as a possible CST for Ontario long-term care home (LTC) residents with
moderate to severe dementia.
I analyzed data of a single site case series (n=24), piloted to explore the feasibility of VR
therapy, residents’ tolerance for the therapy, facilitators and barriers to implementing the
therapy, sensitivity to change, and longitudinal construct validity of the selected BPSD
measuring tools. The VR therapy was provided with Broomx©
(http://www.broomx.com/broomxvr.php) for 30 minutes, five days a week for two weeks.
The analysis revealed that older adults with moderate to severe dementia could tolerate VR
therapy. Strategies such as use of Broomx© projector instead of headset, tailored VR library
items, and a soundproof room with no visual distractions facilitated, whereas residents’
conflicting schedule (e.g. an unplanned family visit) challenged, VR implementation. The
selected measuring tools (Cohen-Mansfield Agitation Inventory, Cornell Scale for
Depression in Dementia, and proportion of night-time sleep) were sensitive to change and
were valid. The logistics of collecting these measures were of concern since they were
additional to mandated outcomes and had to be completed by Personal Support Workers.
I also performed an interpretive description using semi-structured interviews (n=15) with
individuals positioned to observe the residents during the pilot. In my interpretation,
residents’ mood, demeanor, and daily activities improved noticeably during VR therapy.
Several issues (e.g. VR library items, therapy schedule, staff commitment) were important in
implementing the therapy.
Based on the findings from both studies, I designed a matched-pair cluster randomized
control trial (CRT) as the next proposed step using mandated outcome measures in 659
participants or 28 LTC homes or 14 matched-pairs to evaluate if usual care and VR therapy
ii

can reduce BPSD in older adults with moderate to severe dementia living in Ontario LTC
compared to usual care alone, useful in clinical decision making. The CRT also will compare
the cost between the intervention and control.

Keywords
Behavioural and psychological symptoms of dementia, virtual reality, long-term care home,
interpretive description, cluster randomized control trial
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Lay Summary
Individuals with dementia often express deteriorating responsive behaviours, also known as
Behavioural and Psychological Symptoms of Dementia (BPSD), as their condition
progresses. Cognitive stimulation therapy (CST) has been shown to reduce BPSD. CST
refers to a structured approach to engage individuals using mental stimulation. I wanted to
explore the potential of virtual reality (VR) as a possible CST in managing BPSD. I analyzed
pilot study data that involved 24 older adults with dementia living in a long-term care facility
and performed an interpretive description using a series of semi-structured interviews (n=15)
with individuals positioned to observe pilot study participants. The VR therapy was provided
using a Broomx© (http://www.broomx.com/broomxvr.php) for 30 minutes, five days a week
for two weeks. I found that VR therapy is feasible and participants’ BPSD were reduced
noticeably during the therapy. I also designed a cluster randomized control trial to evaluate if
VR therapy can reduce BPSD in this population and to compare cost of VR therapy to usual
care.
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Chapter 1
1

Introduction

This doctoral thesis follows an integrated article style including five chapters. Chapter 1
is an introduction detailing the topic of interest, my motivation towards writing this
thesis, and brief description of thesis chapters. The research questions that inspired this
thesis were rooted in caregiver frustrations to managing difficult behaviours associated
with dementia. Dementia is the fifth leading cause of death worldwide (World Health
Organization, 2017) and the seventh leading cause of death in Canada (Statistics Canada,
2018).

1.1

What is dementia?

Galenus, a notable Greek physician, described dementia as cognitive deterioration of old
age in the 2nd century A.D. and called the condition, “morosis” (Berchtold & Cotman,
1998). In 1907, German psychiatrist Alois Alzheimer reported plaques and tangles in the
brain of a 51-year-old woman with cognitive impairment (Alzheimer, 1906). Later, the
condition was named Alzheimer’s disease (Berrios, 2017). Researchers noted that
plaques and tangles in the hippocampus and surrounding areas of the brain were spared or
negligibly atrophied during normal aging (Jack, Petersen, Xu, O’Brien, Smith, & Ivnik,
1998; de Toledo-Morrell, Goncharova, Dickerson, Wilson, & Bennett, 2000). The
scientific community was divided for a century on whether Alzheimer’s disease and agerelated dementia were the same condition (Berrios, 2017). In response to that
disagreement, the Diagnostic and Statistical Manual of Mental Disorders (5th ed.)
(DSM-V) categorized dementia as a major neurocognitive disorder (American
Psychiatric Association [APA], 2013). The diagnostic criteria for dementia are: 1)
cognitive deficit has not been present since birth or very early life, 2) a decline of
cognitive function from a previously attained level of functioning, 3) cognitive decline
interferes with independence or activities of daily living of the affected person, and 4) the
cognitive decline is not due to delirium or other mental disorder (APA, 2013).
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There are six domains of cognitive function that may be affected in dementia: 1) complex
attention, 2) executive function, 3) learning and memory, 4) language, 5) visuoconstructional-perceptual ability, and 6) social cognition (APA, 2013). According to
DSM-V, dementia can be further subcategorized by the underlying pathology of the
condition, the presence or absence of behavioural disturbances, and the severity of the
condition across clinical stages (mild/moderate/severe) (APA, 2013). The common types
of dementia based on the underlying pathology in order of prevalence are Alzheimer's
dementia (60%-70%) (WHO, 2019), vascular dementia (20%), Lewy Body dementia (515%), and frontotemporal dementia (2.5%-8%) (Duong, Patel, & Chang, 2017; Onyike,
& Diehl-Schmid, 2013; Usman, Oskouian, Loukas, & Tubbs, 2017). Clinicians and
scientists agree that a single pathological feature is highly unlikely to cause dementia
(Berrios, 2017).

1.2

What are difficult behaviours associated with dementia?

Difficult behaviours associated with dementia are also known as Behavioural and
Psychological Symptoms of Dementia (BPSD). I will use the term BPSD throughout this
paper from this point forward. BPSD include but are not limited to symptoms such as
apathy, depression, agitation, aggression, sleep disorders, and psychosis (O'Donnell,
Drachman, Barnes, Peterson, Swearer, & Lew, 1992). Depression and apathy are
common in vascular dementia (Kales, Gitlin, & Lyketsos, 2015). Frontotemporal
dementia typically presents with gross decline in behaviours (BPSD) and
speech/language (Onyike et al., 2013) with disinhibition and eating disturbances being
common (Kales et al., 2015). In Alzheimer's dementia, delusion is common (Kales et al.,
2015).
Apathy is characterized by a lack of emotional responsiveness (Tagariello, Girardi, &
Amore, 2009). On the other hand, depression symptoms include loss of energy/interest,
change in appetite, impaired concentration, insomnia, sadness, anhedonia, suicidal
ideation, self-blame, weight change, sexual disinterest, and hypersomnia (Fried,
Epskamp, Nesse, Tuerlinckx, & Borsboom, 2016). Apathy and depression in individuals
with dementia are associated with other behavioural symptoms (Levy et al., 1998). For
instance, apathy is associated with disinhibition and abnormal motor behaviour, whereas
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depression is associated with anxiety, agitation, irritability, and hallucinations (Levy et
al., 1998).
Typically, agitation is referred to as inappropriate verbal, vocal, or motor activity that
cannot be otherwise explained (Cohen-Mansfield & Billig, 1986). Agitation may include
rejection of care, noncompliance, uncooperative behaviour, resistance to care, and
aggression (Choi, Budhathoki, & Gitlin, 2017). Aggression can be explained as
deliberate, overt, and harmful acts toward another person, object, organism or one’s self
(Patel & Hope, 1992). Possible causes of agitation/aggression in individuals with
dementia include pain, medical illness, loneliness, boredom, medication side effects,
environmental changes, and fatigue (Lyketsos et al., 2011).
Sleep disorders in individuals with dementia includes difficulty falling asleep or staying
asleep, sleep fragmentation, wandering, and excessive daytime sleepiness (Moran, Lynch,
Walsh, Coen, Coakley, & Lawlor, 2005). The causes of sleep disorders in individuals
with dementia may include disturbances of their circadian rhythm, pain or discomfort,
medications, anxiety, and depression (Kinnunen, Vikhanova, & Livingston, 2017).
Disturbances in circadian rhythm refer to early sleep onset and offset, late sleep initiation
and rise time, and irregular sleep–wake rhythm (Pavlova, 2017). The neurodegenerative
changes in dementia (deposition of amyloid and tau) can impair melatonin production
and release from the brain that consequently may affect the circadian rhythm (Ju, Lucey,
& Holtzman, 2014). A five-year retrospective survey on institutionalized individuals with
dementia (n=2447) reported sleep disorders as common complaints (> 50% of cases) in
later stages of the condition irrespective of types of dementia (Kazui et al., 2016).
Inadequate or poor-quality night-time sleep can impact a person’s daytime functioning
and quality of life (Kyle, Espie, & Morgan, 2010).
According to the DSM-V and the World Health Organization (WHO), the central concept
of psychosis is impaired reality (APA, 2013; WHO, 1992). Hallucinations (without
insight into their pathologic nature), delusions, or both are present in psychosis (APA,
2013; WHO, 1992). Psychotic symptoms are less common than depression, agitation, and
sleep disorders in individuals with dementia (Fauth & Gibbons, 2014). However,
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psychosis can be a source of distress for both individuals with dementia and their
caregivers.

1.3

Burden of BPSD

BPSD worsen as dementia progresses (Stern, Mayeux, Sano, Hauser, & Bush, 1987) and
intensifies caregiver distress (Allegri et al., 2006) leading to caregivers’ decision to
institutionalize their loved ones (Steele, Rovner, Chase, & Folstein, 1990). Family
members of individuals with dementia also reported that their loved ones’ difficult
behaviours were the reason for their decision to place them in a long-term care (LTC)
home (Yaffe et al., 2002; Buhr, Kuchibhatla, & Clipp, 2006).
A North American population-based prevalence study capturing 10 years of data from
362 individuals with dementia revealed that 75% (n=270) of them had exhibited at least
one difficult behaviour (Lyketsos, Lopez, Jones, Fitzpatrick, Breitner, & DeKosky,
2002). A meta-analysis using 228 studies on the association of caregiver burden and
dementia care revealed that BPSD imposed the greatest burden on the caregivers (r=0.37,
95% confidence interval [CI]=0.35–0.39) (Pinquart & Sorensen, 2003).
BPSD can harm (physical injuries, emotional trauma, and death) the individual exhibiting
the behaviours, his/her caregivers, and people cohabitating with him/her (Caspi, 2015;
2016; Shinoda-Tagawa, Leonard, Pontikas, McDonough, Allen, & Dreyer, 2004).
Caregivers are at higher risk of physical injuries and emotional stress as BPSD are
reported to manifest more during direct care such as toileting, bathing, mouth care,
feeding, and dressing (Lachs et al., 2013; Morgan et al., 2012).

1.4

How to manage BPSD?

The Registered Nurses’ Association of Ontario (RNAO, 2016) completed a best practice
guideline on dementia management based on current evidence. They recommended nonpharmacologic interventions (e.g. Cognitive Stimulation Therapy [CST]) to manage
BPSD for individuals with dementia, irrespective of drug treatments received (RNAO,
2016). The CST stimulates and engages individuals with mental stimulation,
reminiscence, orientation, and a focus on opinions in a structured way (Morley & Cruz-
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Oliver, 2014). Listening to music, singing, dancing, reading, painting, drawing, cooking,
knitting, talking, listening to others, playing with a pet, and playing video games had
been used as CST in various clinical setting (Morley & Cruz-Oliver, 2014; Zelinski &
Reyes, 2009). The Virtual Reality (VR) experience also is considered as a CST (D’Cunha
et al., 2019).

1.5

Why am I interested?

I am a physician (Dhaka University, Bangladesh) with a Master’s in Public Health
(Sydney University, Australia). I spent five years in community health research in several
parts of the world (Bangladesh, India, Nepal, and Kenya). I also coordinated clinical
research related to cognitive health in Ontario, Canada for three years. I became
interested in dementia management while working with cognitive health and decided to
pursue a doctoral degree to gain deeper understanding in dementia management.
While serving in my role as a Research Associate at London Health Science Centre, I
noticed that BPSD aggravated caregiver burden. The family caregivers accompanying the
research participants often mentioned that their loved ones might need institutional care. I
was curious to learn what happened to LTC residents with BPSD. Certainly, their
symptoms did not resolve once institutionalized. I wanted to learn how LTC homes
managed BPSD.
My supervisor (DB) introduced me to a researcher (KC) who was interested in ways to
reduce BPSD for LTC residents. She (KC) and her colleagues invited my supervisor and
I to their internal meeting to discuss a recent pilot study they had completed. Her
intervention was a CST (VR therapy). I was interested in learning more about this
intervention and its potential use in health care.
I also am a mother of a teenage son. I was concerned about the extensive amount of time
that my son spent playing video games and experiencing VR since his childhood; even to
the point of falling behind on his grades. I learned from other parents that they had
similar issues with their children. I limited his screen-time, but my action failed to
improve his grades. I decided to embrace the idea that the virtual world was not the
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demon to blame. I worked with his guidance counsellor at school and motivated him to
select a career path that would enable him to create his own virtual world. His story
changed from then on. He made progress in school activities; he invested his time in
searching universities offering courses in Software Engineering; and developed a career
goal. The experience made me realize that video games and VR are our future and we
must think out of the box in finding new ways to use the technology for better.
During the meeting, KC and her colleagues shared their own observations of pilot
participants’ behaviour changes. They mentioned that the family members of those
participants and LTC (Henley Place) staff observed similar behavioural changes. Despite
my belief in the objective reality of VR effect, I acknowledge the existence of multiple
realities. With this in mind, I wanted to conduct a qualitative inquiry into this pilot study.
My supervisors and Advisory Committee agreed that this was a worthy line of inquiry.

1.6

The research question

I conducted three separate projects to answer the overarching research question: In LTC
residents with dementia, can VR be used as a CST to reduce BPSD compared to usual
care? The first project was a pilot study evaluating the feasibility of VR therapy in LTC
resident older adults with moderate to severe dementia. I analyzed the data of the pilot
study to determine 1) whether VR therapy is a feasible intervention for older adults with
moderate to severe dementia, and 2) whether the selected outcomes were valid and
sensitive to change in this population. The participants of the pilot were older adult
residents of Henley Place in London, ON who had moderate to severe dementia and the
intervention was VR experience with BroomX©
(http://www.broomx.com/broomxvr.php) for 30 minutes a day, five days a week for two
weeks.
The second project was a qualitative inquiry to explore the perceptions of individuals
positioned to observe pilot participants. I designed and conducted the project using
interpretive description as method to understand the informants’ perceptions.
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The third project was a protocol for a Cluster Randomized control Trial (CRT) as the
next research step aiming to evaluate the effect of VR therapy. I designed the protocol
with a primary research question being if usual care and VR therapy (intervention) can
reduce BPSD in older adults with dementia living in Ontario LTC compared to usual care
alone (control). The CRT also is designed to perform a cost comparison between the
intervention and control.

1.7

Plan of presentation

Chapter 2 of this thesis presents the pilot study. The driving force behind investigating
VR therapy as a potential treatment for persons with dementia came from JK, who is the
Chief Operating Officer for primacare Living Solutions Inc.™, which owns several longterm care facilities in southwestern Ontario. Her experiences in caring for individuals
with dementia and recognition that there are no great solutions to reduce BPSD in this
population, made her welcome research into new ideas for reducing these behaviours
while still maintaining quality of life. To date, there is no published work on this topic.
Chapter 3 of this thesis presents an interpretive description of informants’ perceptions of
Henley Place residents who participated in the VR pilot, previously not identified as
possible outcome of the pilot. The informants for this qualitative study were family
members, Henley Place staff members, and pilot researchers.
Chapter 4 of this thesis presents the protocol for a matched-pair CRT based on findings
from the pilot study and the qualitative inquiry. Chapter 5 of this thesis discusses the
rationale for choosing CRT design, ethical issues related to randomization scheme and
consenting, estimation of sample size, analysis scheme, dealing with missing data, and
directions for future research.
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Chapter 2
2

Virtual reality therapy in long-term care resident older adults

with dementia: A case series
2.1

Chapter summary

BACKGROUND: Behavioural and psychological symptoms of dementia (BPSD)
worsens as dementia progresses, intensifies caregiver distress and consequent
institutionalization of the individuals with dementia. A pilot study was conducted to
evaluate the feasibility of virtual reality (VR) as Cognitive Stimulation Therapy (CST)
for BPSD in a long-term care (LTC) home. METHODS: A single site (Henley Place at
London, Ontario) case series with a convenience sample (n=24). Intervention was 30
minutes of VR therapy with Broomx© (http://www.broomx.com/broomxvr.php), five
days a week for two weeks. The change in BPSD was measured with Cornell Scale for
Depression in Dementia (CSDD), Cohen-Mansfield Agitation Inventory (CMAI) scale,
Dementia Observation System (DOS) scale, and proportion of night-time sleep. We
validated selected tools with Global Rating of Change (GRC) scale. RESULTS:
Implementing VR therapy was possible at Henley Place (recruitment rate=40%, the
adherence rate=21%, and the attrition=0%) and residents could tolerate it. No emergency
transfers or 24 hours continuous one-to-one staff use were recorded during the
intervention period. CONCLUSION: VR therapy can be implemented in a LTC home.
The ethics approval was obtained from ADVARRA Canada Ethics Board before
recruiting residents for the study (See Appendix A for ethics approval).

2.2

Background

Dementia is a progressive neurocognitive condition, predominantly affecting older adults
that evolves to disability and, eventually, mortality (National Institute for Health and
Care Excellence [NICE], 2013). There is no cure for dementia (NICE, 2013). According
to the Public Health Agency of Canada (PHAC, 2017), the number of Canadians with
dementia was about 402,000 in 2014. The annual dementia incidence rate in Canada was
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360 per 100,000 people in 2011 (PHAC, 2012). In 2016, dementia ranked the fifth
leading cause of death worldwide (Nichols et al., 2019). Dementia accounted for 6.3%
(95% CI 5.4% to7.5%) of disability-adjusted life in years for people aged 70 years and
over (Hay et al., 2016).
BPSD is common in people with dementia (Lyketsos et al., 2002). The most frequently
reported BPSD were anxiety/agitation/aggression (52%; 95% CI, 47% to 57%), apathy
(36%; 95% CI, 31% to 41%), depression (32%; 95% CI, 28% to 37%), sleep disturbance
(27%; 95% CI, 23% to 32%) and irritability (27%; 95% CI, 23% to 32%) (Lyketsos et al.,
2002).
BPSD are usually measured with subjective psychometric tools, originally developed to
rate feelings or opinions or attitudes (Linde, Stephan, Dening, & Brayne, 2014). A
systematic review located 83 BPSD tools focusing either on depression (n=46) or
irritability (n=37) or non-aggressive agitation (n=26) or anxiety (n=22) or hallucination
(n=21) or delusion (n=20) or wandering (n=22) or apathy (n=17) or sleep problems
(n=14) (Linde et al., 2014). According to Linde and colleagues (2014), the frequently
used BPSD tools for older adults in clinical settings are the Cambridge Mental Disorders
of the Elderly Examination (CAMDEX) (Roth et al., 1986), the Geriatric Mental State
Schedule (GMS)/Automated Geriatric Examination for Computer Assisted Taxonomy
(AGECAT) (Copeland et al., 1976), the Apathy Evaluation Scale (AES) (Marin,
Biedrzycki, & Firinciogullari, 1991), the Geriatric Depression Screening scale (GDS)
(Yesavage et al., 1982), the Neuro Psychiatric Inventory (NPI) (Cummings, Mega, Gray,
Rosenberg-Thompson, Carusi, & Gornbein, 1994), CSDD, and CMAI.
We did not select CAMDEX and GMS/AGECAT for our pilot as they are predominantly
diagnostic tools, irrelevant to our objective. We also did not select AES and GDS as they
are self-reported, which is not suitable for our participants. Even though the NPI is a
validated clinical tool designed explicitly to provide a comprehensive evaluation of
BPSD (Kaufer et al., 1998), raters' tight work schedule can deviate the original NPI
protocol (e.g., an arbitrary evaluation of symptoms is made based on the general domains
instead of using sub-questions) (Connor, Sabbagh, & Cummings, 2008) or can lead to a
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possible recall bias (e.g. rating is based on retrospective information [one month]) (Stella
et al., 2013; 2015). Therefore, considering tight work schedule of LTC staff members and
possible recall bias, we did not select NPI.
Managing BPSD is often challenging as the causal relationship of the symptoms and
pathophysiology is complex (Tible, Riese, Savaskan, & von Gunten, 2017). For example,
an individual with dementia may exhibit BPSD due to pain, necessitating pain
management instead of psychotherapy (Corbett et al., 2012). Available
pharmacotherapies for BPSD have limited effectiveness because of possible serious sideeffects resulting from multi-morbidity or polypharmacy or age-related altered metabolism
(Reus et al., 2016). Consequently, BPSD management is increasingly focusing on
maintaining an optimal quality of life with non- pharmacotherapies (Shaji, Sivakumar,
Rao, & Paul, 2018).
VR therapy is a type of non-pharmacotherapy (CST) focusing on sensory stimulation that
offers a computer-generated virtual environment imitating real world and can create an
experience of a physical reality (Wiederhold, 2018). An individual using VR therapy can
look around or move around in an artificial world (Wiederhold, 2018 ). This technology
requires the user to either use a headset or a projector (e.g. BroomX©) to generate
realistic images, sounds and other sensations that simulate an user's physical presence in
a virtual or imaginary environment (Wiederhold, 2018). BroomX© provides the
immersive experience through a projection device having automatic control to conform
the visuals to a 3600 experience no matter the size of the room, or what furniture is in the
room (The Projected VR Company, 2019).
Our objectives were to determine, 1) the rate of recruitment, adherence and attrition; 2)
residents’ tolerance for the VR therapy; 3) facilitators and barriers to implementation of
VR therapy; 4) the sensitivity to change of selected outcome measures; and 5) the
longitudinal construct validity of selected outcome measures within a sample of older
adults with moderate to severe dementia undergoing VR therapy.
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2.3

Methods

2.3.1. Study design and participants
The design was a single site case series (before-after intervention study). The participants
were 1) older adults (aged ≥ 65 years), 2) residing in Henley Place LTC at London, ON,
Canada with 3) dementia (a Cognitive Performance Scale [CPS] score [Morris et al.,
1994] between 3 to 5), and 4) exhibiting BPSD. Ontario LTC homes regularly evaluate
their residents’ cognition with CPS score (Canadian Institute for Health Information
[CIHI], 2010a). The CPS includes four areas: memory, decision-making skills,
communication and eating (Morris et al., 1994). Individuals experiencing no difficulties
in these four areas score 0, while individuals having severe memory problems and are
unable to make daily decisions or feed themselves or are comatose score 6 on the CPS
scale (Morris et al., 1994). A CPS score 0 indicates no dementia, whereas a score of 1-2
indicates mild, score of 3 indicates moderate, and score of 4-6 indicates severe dementia
(Morris et al., 1994).
Those diagnosed with 1) epilepsy, those who were 2) blind, 3) at end of life, and 4)
unable to communicate in English, and had 5) Substitute Decision-Maker (SDM)
appointed as Public Guardian and Trustee were ineligible to participate.
Henley Place (http://primacareliving.com/ltc/henley_place/) staff member identified the
possible participants using their CPS score. Once identified, the Henley Place staff spoke
with participants’ SDM face-to-face or by phone to learn if the SDM would agree to be
contacted for possible study participation. Once agreed, the Principal Investigator (PI,
KC) and Research Assistant (RA) contacted the SDM from November 26, 2018 to
January 04, 2019 to recruit participants.
2.3.2

Intervention

The intervention was VR therapy using BroomX©
(http://www.broomx.com/broomxvr.php). The VR experience was provided with a
headset at the beginning of the 2-week intervention period to five participants. PI (KC)
and RA noticed that the participants felt uncomfortable using the headset as it limited

12

their vision, was too loud, and was heavy. Moreover, the pilot study was conducted in
December and January, which is flu season in Ontario LTC. Therefore, they (PI, RA)
disinfected the headset after each use with a disinfecting liquid, challenging the time
management of the intervention. To accommodate participants’ discomfort and
practicality of time management, VR experience was provided with BroomX© projector
instead of a headset from then on.
Broomx© consists of a MK Player 360© hardware and a software (Broomx
Technologies, 2019). A MK Player 360© is a projection device with light and sound
control that can display 3600 videos on a frameless screen (a room) (Broomx
Technologies, 2019). The Broomx© software provides interactive content accessed by a
smartphone app (See Figure 1: Technical information on Broomx©) (Broomx
Technologies, 2019). This technology is currently being used in hotels, restaurants, night
clubs, retail and exhibitions, and healthcare (Broomx Technologies, 2019).

Figure 1. Technical information on Broomx©. Reprinted from “MKplayer360” by
Broomx Technologies, 2019, Retrieved from http://www.broomx.com/mkplayer360.php
Copyright 2019 by Broomx Technologies. Reprinted with permission.
A MK Player 360© projector was used either in a predetermined intervention area or in
the participants’ own room depending on their mobility status. Participant’s TV was
covered, his/her wall hangings were brought down, his/her windows and door curtains
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were closed for a clearer visualization of VR images when setting up MK Player 360©
projector in a participant’s room. Participants got agitated when PI (KC) and RA were
setting up the hardware and software in their own rooms. PI (KC) and RA also realized
that assembling and disassembling VR hardware in the participant’s own room was time
consuming during the first week of the intervention period. From that time forward, the
RA assembled the BroomX© in the intervention area before the participant entered the
room.
The maximum duration and frequency of the intervention was 30 minutes, five days a
week (Monday to Friday) for two weeks. The timing of the intervention was customized
for each participant to avoid their usual lunch time, visiting hours, and nap time.
However, the two-week intervention schedule was fixed for the convenience of the
project. If a participant missed the intervention for the day for any reason, there was no
makeup session on a different day. Crosswater Digital Media (https://crosswater.net/ )
developed a library with pleasing images of nature, set to music (72 beats/minute) for this
study. The RA selected the library items for each participant personalized to his/her
experiences and preference according to information supplied by family members. If a
participant preferred a particular library item, the RA selected that item several times.
There was no limit to the frequency or variety of the played library items. The
intervention was stopped if the participants became agitated with a specific VR library
item.
The staff (Personal Support Worker [PSW]) caring for the residents were on call during
the intervention in case a participant needed assistance. Throughout the 30-minute
session, RA sat by the participant and held participant’s hand if requested. The risk for
falls, was reduced by having the RA sit with the participant at all time.
2.3.3

Outcome Measures and Statistical Methods

To address objective 1, we measured: a) the proportion of consenting participants to
eligible participants over the 6-week recruitment period, b) the proportion of participants
attending 10 intervention sessions to the number of participants allocated to the
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intervention, and c) the proportion of participants with incomplete outcome data to the
number of participants allocated to the intervention.
To address objective 2, we measured a) the proportion of participants who were able to
tolerate at least 80% of the planned sessions b) the mean length of participants’ VR
experience in minutes per session, c) number of times each type of negative behaviour
was observed and the proportion of participants who experienced each negative
behaviour during the 30-minute session, d) number of times each type of positive
behaviour was observed and the proportion of participants who experienced each positive
behaviour during the 30-minute session, e) number of Adverse Events (AE) during the
intervention period, f) health care resources used (i.e. the number of participants
requiring transfers to emergency, number of participants requiring 24 hour continuous
one-to-one staff use, psychotropic drug prescription, and change in quality of life
questionnaire) to indirectly indicate their tolerance to VR therapy.
According to the Need Driven Behaviour Model (Algase et al., 1996), an individual with
dementia expresses his/her physical/emotional needs or exhibits his/her dementia
symptoms through physical/verbal expressions/gestures. As per this model, we reported
the following behaviours as “negative”: agitation, wandering, hitting (including self),
kicking, grabbing onto people, pushing, throwing objects, biting, scratching, spitting,
hurting self or others, tearing objects or destroying property, making physical/verbal
sexual advances, inappropriate dressing or disrobing, intentional falling, eating/drinking
inappropriate substance, handling objects inappropriately, hiding objects, hoarding
objects, performing repetitive mannerisms, screaming, cursing or verbal aggression,
repetitive sentences or questions, strange noises (weird laughter or crying), complaining,
constant unwarranted request for attention or help, pulling away/walking away,
perseveration of word/repetitive talking, raising tone of voice, resisting, and not eating.
We labeled the following behaviours as “positive”: being seated still, being focused,
sleeping, being calm, smiling, and communicating verbally/non-verbally, based on staff
members’ experience with the residents at Henley Place LTC.
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For this pilot, we defined AE as any event leading to emergency transfer, hospitalization,
death, a persistent or significant incapacity or substantial disruption of the participants’
ability to conduct the activities of daily living for being in a VR therapy session. We
reported AE regardless of a contemporaneous relationship with VR therapy.
Use of health care resources such as transfers to emergency and one-to-one staff usage
indicated acute decline or worsening of a participant’s health. For instance, Henley Place
may provide a resident one-to-one staffing if he/she causes another resident a physical
incident or a sexual incident; becomes physically aggressive (non-manageable) with drug
and other therapy; has history of a similar behaviour that ended up on having one-to-one
staff usage in the recent past; is in risk of potential self-harm; exhibits an agitated
aggressive behaviour or a wandering behaviour; and is at risk of being victimized by
other residents. Psychotropic drugs refer to any drug affecting mental processes and
behaviour (Schulz & Steimer, 2000). Psychotropic drugs include, but are not limited to,
antipsychotics, antidepressants, antianxiety drugs, mood stabilizers, anticonvulsants, and
hypnotics (Schulz & Steimer, 2000 ). We used a generic quality of life questionnaire
(Euro-Qol 5-Dimention scale [EQ-5D]) for this pilot. EQ-5D has five domains: mobility,
self-care, usual activities (e.g. work, study, housework, family or leisure activities),
pain/discomfort, and anxiety/depression with five possible answers for each domain
(1=no problem, 2=slight problem, 3=moderate problem, 4=severe problem, 5=unable to
do/extreme problem) (EuroQoL Group, 1990). The scale is feasible for individuals with
dementia (Schrag, Selai, Jahanshahi, & Quinn, 2000).
Either KC or RA recorded and labelled participants’ behaviours during the VR sessions
based on her direct observation, completed VR therapy records and AE forms, and
archived the number of emergency transfers, one-to-one staff usage, and psychotropic
drug prescription from the participant’s medical chart. The Henley Place staff members
completed the EQ-5D scale.
To address objective 3, we reported a) the number of times a library item was selected,
b) whether the SDM was present during the VR sessions, and c) factors that were
observed to be enabling (perceived to contribute to successful session) or d) disabling
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during the VR experience from the VR therapy records completed by either KC or RA
(perceived to contribute to unsuccessful session).
To address objective 4, we collected the pre-to post (before any VR therapy took place
[baseline] and at the end of second week of therapy) change of BPSD with CSDD
(Alexopoulos, Abrams, Young, & Shamoian, 1988), CMAI scale (Cohen-Mansfield,
1986), proportion of night-time sleep, and DOS scale (Marshall, Cuperfain, Tsokas, &
Iaboni, 2016). We reported the scales’ sensitivity to change with Effect Size (ES).
We selected CSDD as it is feasible for those with advanced dementia (Alexopoulos et al,
1988). The 19-item CSDD detects depression in dementia, and includes five domains:
mood, behaviour, physical signs, cyclic function, and ideation, from interviews with a
caregiver (Alexopoulos et al, 1988). Each item is rated for severity based on symptoms
occurring during the week before the interview on a scale of 0-2 where 0 indicates no
symptoms and 2 indicates severe symptoms (Alexopoulos et al, 1988). The interrater
reliability (k=0.67) and internal consistency (α=0.84) of the instrument is high
(Alexopoulos et al, 1988). The association between CSDD and Research Diagnostic
Criteria Depression (Spitzer, Endicott, & Robins, 1978), a scale measuring similar
construct, also is strong (r=0.83, p < 0.001) (Alexopoulos et al, 1988).
We selected 29-item CMAI tool as it is applicable for LTC residents (Linde et al., 2014).
The CMAI tool assesses the agitated behaviours within four components: 1) Physical
Aggressive (PA), 2) Physical Non-Aggressive (PNA), 3) Verbal Aggressive (VA), and 4)
Verbal Non-Aggressive (VNA) (Cohen-Mansfield, 1986). Each behaviour is rated on a 7point scale of frequency, ranging from the resident never manifesting the behaviour (1) to
manifesting the behaviour several times an hour (7) (Cohen-Mansfield, Marx, &
Rosenthal, 1990). The scale is reliable (test-retest reliability coefficient=0.830; p<0.001)
(Koss et al., 1997) in individuals with dementia and has demonstrated construct validity
(i.e. strong association with a similar scale, Agitated Behaviour in Dementia, r=0.62;
p<0.001) (Logsdon et al, 1999).
Sleep disturbance (e.g. difficulty falling asleep, repetitive sleep awakenings, and waking
up early) is a risk factor for developing depressive symptoms (Arbus et al., 2011), apathy
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(Mulin et al., 2011), and aggressiveness (Moran et al., 2005) in dementia. Sleep
disturbance may also indicate comorbidities (Bubu et al., 2017). The association between
sleep disturbance with Pittsburgh Sleep Quality Index (Buysse, Reynolds, Monk,
Berman, & Kupfer, 1989) and NPI-Apathy domain is moderate (r=0.38; p<0.01) (Shin,
Han, Shin, Park, Lee, & Park, 2014). Thus, proportion of night-time sleep indirectly
predicts BPSD (Shin et al., 2014). Since Henley Place routinely records residents’ nighttime sleep as a proportion of the total expected asleep time (8 hours, from 10:00 pm to
6:00 am each night), we opted to measure sleep using methods already in place.
We selected DOS as it is designed to be completed by LTC staff members (DOS
Working Group, 2019). The scale evaluates objective and accurate data about an
individual’s behaviour throughout each 24-hour cycle over a period of several
consecutive days to identify patterns, trends, contributing factors and modifiable
variables associated with BPSD (DOS Working Group, 2019). The rater records duration
of observed behaviours (sleeping, awake/calm, positively engaged, repetitive vocal and
motor expressions, and sexual/ verbal/physical expression of risk) using number of half
an hour blocks and colour codes (DOS Working Group, 2019).
We invited the SDM to complete the CSDD, CMAI, and DOS scale. However, the SDM
felt that the regular staff (PSW and Registered Practical Nurses [RPN]) could more
accurately complete these tools since they provide care for the residents 24/7. PI (KC)
trained PSW and RPN employed at Henley Place to complete the above-mentioned tools.
Scales were completed at baseline, at the end of first week, and at the end of second week
of therapy. PI (KC) extracted participants’ proportion of night-time sleep at baseline, at
the end of first week, and at the end of second week of therapy from their medical chart.
Sensitivity to change of a tool is its ability to detect change (signal over noise) regardless
of whether the change is meaningful to the clinician or decision maker (Liang, 2000). The
most appropriate statistic for sensitivity to change remains a matter of debate (Beaton,
Hogg-Johnson, & Bombardier, 1997). Usually, for a single group index, sensitivity to
change is reported using ES (Finch, Brooks, & Stratford, 2002). ES analysis is based on
the assumption that the participants are homogenous at the baseline and may exhibit a
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change by approximately the same amount over the study period (Stratford & Riddle,
2005). ES is expressed using a ratio of mean change scores (𝛿x=x2- x1) to the Standard
Deviation (SD) of the baseline scores (Cohen, 1988). For both statistics, if change has
occurred, a value greater than 1.0 indicates that the instrument is sensitive to change. We
selected ES to report the sensitivity to change as ES to determine the sample size (Cohen,
1988) for future research and to facilitate comparison between studies in future metaanalyses (Maxwell & Delaney, 2004).
To address objective 5, we explored the association of pre-to post change scores
between week 1 and pre-intervention and again between week 2 and week 1 for the
CSDD and CMAI with the GRC using Pearson’s r (rho) or coefficient r on SPSS©
version 26. The GRC scale captures an individual’s perspective (in this case, participants’
caregivers) regarding their change in health condition (in this case, depression and
agitation) (Jaeschke, Singer, & Guyatt, 1989). The scale quantifies the change (from a
small, unimportant change to a very great deal of change) using scores 0 to 7 (0=no
change, +1 to +7= a perceived improvement in condition, and -1 to -7= a perceived
deterioration in condition) (Jaeschke et al., 1989). We classified GRC as a lot worse
(GRC=-6,-7), moderately worse (GRC=-4, -5), minimally worse (GRC=-1, -2, -3), stable
(GRC=0), minimally better (GRC=1, 2, 3), moderately better (GRC=4, 5), and a lot better
(GRC=6, 7). We had two outliers for GRC-depression (GRC=-4 [n=1] at the end of the
first week and GRC=7 [n=1] at the end of the second week). On the same note, we had
one outlier for GRC-agitation (GRC=-4 [n=1] at the end of first week and second week).
To demonstrate longitudinal construct validity, we expected that a GRC rating of 0 would
be associated with little to no change in the CSDD/CMAI (i.e. a change score of 0).
Considering the short period of intervention (two weeks), we did not expect many
participants to experience very large changes, thereby reducing the breadth of the scale
and reducing the magnitude of the association. Thus, our a priori hypothesis for the
correlation between CSDD/CMAI and GRC was weak to moderate. The categorization of
the strength of correlation using coefficient r was strong when r ≥0.6, moderate when
r=0.3 to 0.6, and weak when r ≤0.3 (Cohen, 1988).
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2.3.4

Sample Size

We felt that approximately 40% of participants would be eligible and have an SDM
willing to provide consent to participate in the trial from Henley Place (192 bed
capacity). The reason for our low estimate was that attempts to contact the SDM were to
take place during the holiday season (Christmas and New Year), which did not optimize
access. To maximize the recruitment, the RA contacted SDM on weekdays from 9 to 5
and kept the study phone open on evenings and weekends for them to call back. The RA
also went into Henley Place after hours to meet SDM in the evenings and weekends.
Given this estimate, to be 95% confident we needed 18-27 eligible participants (and their
SDM) in the population to provide consent (Dhand & Khatkar, 2014).

2.4

Results

We presented the number of eligible participants who were approached, screened,
signed/withdrew informed consent, received/not received the intervention, lost to follow
up/discontinued, and analyzed, describing the reasons for each one in Figure 2 (The flow
chart for participant enrollment, allocation, follow-up, and analysis).
Six participants failed the screening due to a change of their health condition (CPS score
>5 [n=2], epilepsy [n=1], palliative care [n=1], blind [n=1], unable to communicate in
English language [n=1]). One participant withdrew consent before the intervention
started due to a conflicting family visit schedule. The demographic and clinical
characteristics of the participants are shown in Table 1.
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Table 1
The demographic and clinical characteristics of the participants
Characteristics of participants
Age (mean, standard deviation [SD])
Sex (n, %)
CPS score (mean, SD)
Dementia types:
Alzheimer’s disease (n, %)
Unspecified dementia (n, %)
Comorbidities:
Depression (n, %)
Diabetes mellitus (n, %)
Stroke (n, %)
Concussion (n, %)

85.8 ±8.6
Female (18, 75%)
3.4 ± 0.6
3, 12.5%
21, 87.5%
21, 87.5%
3, 12.5%
2, 8.3%
1, 4.2%

Objective 1. The recruitment rate was (31/77) 40% (95% CI, 29% to 52%), the
adherence rate was (5/24) 21% (95% CI, 7% to 42%), and the attrition was (0/24) 0%
(95% CI, 0% to 12.5%).
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Objective 2. a) 75% of participants were able to complete at least 80% of the sessions.
The maximum number of sessions attended by any participant was 10 and the minimum
number of sessions attended by any participant was two.
b) The average length of participants’ VR experience was 22.2 (95% CI, 23.5 to 20.9)
minutes per session. The shortest length of a session was 1 minute; this participant was
agitated when session started and left the intervention area.
c) The observed negative behaviours were complaining (n=6), restlessness (n=5),
agitation (n=2), calling out for help (n=2), and crying (n=1). Out of the 24 participants,
16 (66%; 95% CI, 45% to 84%) experienced at least one negative behaviour and 5 (21%;
95% CI, 7% to 42%) experienced more than one negative behaviour.
d) The observed positive behaviours were sleeping (n=24), interacting with VR
images/accompanying individuals (n=19), smiling (n=12), singing/humming (n=5),
dancing/tapping feet in rhythm (n=4), and kissing accompanying individual’s hand (n=2).
All (100%) participants experienced at least one positive behaviour and 23/24 (96%; 95%
CI, 79% to 100%) participants experienced more than one positive behaviour.
e) All AE were observed outside the VR sessions and were not related to the intervention.
We noted five AE during the two-week intervention period; falls (n=2), respiratory tract
infection (n=1), loose stool (n=1), and urinary tract infection (n=1).
f) Overall, the pilot participants were relatively stable since none of them were
transferred to emergency four weeks before, during, and after the intervention period.
None of them used one-to-one staff four weeks before and during the intervention period.
However, three participants used one-to-one staff service after the intervention (3/24,
13%; 95% CI, 3% to 32%) (1 participant at post intervention week 2, 2 participants at
post intervention week 3, and 3 participants at post intervention week 4). The dosage of
psychotropic drugs remained either unchanged (14/24, 58%; 95% CI, 37% to 78%) or
reduced (8/24, 33%; 95% CI, 16% to 55%) after the intervention. Eleven out of twenty
four (46%; 95% CI, 26% to 67%) participants were receiving either an anti-psychotic
(Quetiapine) or an anxiolytic (Lorazepam) before the intervention started (at baseline).
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The dose of the antipsychotic was reduced in two of them after the intervention (2/24,
8%; 95% CI, 1% to 27%). Anti-depressants were prescribed to 22/24 (92%; 95% CI, 73%
to 99%) participants at baseline and the drug dosage was reduced in six participants
(25%; 95% CI, 10% to 47%) after the intervention. One participant received a new antidepressant (Citalopram) after the intervention (4%; 95% CI, 0% to 21%). The frequencies
and proportions by EQ-5D dimensions and level indicate no detectable change in
participants’ health condition from baseline to end of second week of intervention (Table
2). Following van Hout and colleagues’ (2012) work, we measured EQ-5D index value
with Crosswalk value set for North America (https://euroqol.org/eq-5d-instruments/eq5d-5l-about/valuation-standard-value-sets/crosswalk-index-value-calculator/). EQ-5D
value indicated no detectable change in participants’ health condition (index value mean
for EQ-5D ±SD at baseline=0.4±0.2; at week-1=0.4±0.3; and at week-2=0.4±0.3).
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Table 2
Distribution of EQ-5D dimension responses at baseline, week 1 and week 2 with index
value
EQ-5D
Baseline
profile

EQ-5D
Baseline index
value

EQ-5D
Week-1
profile

EQ-5D
Week-1
index value

EQ-5D
Week-2
profile

EQ-5D
Week-2
index value

22432
55355
55435
35322
35543
15411
11121
44532
23423
55511
55513
15521
14411
55543
24532
34433
12421
25534
45523
54333
23311
23244
24222
25431

0.6
-0.1
0.1
0.4
0.3
0.5
0.7
0.4
0.6
0.2
0.2
0.4
0.7
0.1
0.4
0.5
0.7
0.3
0.3
0.2
0.8
0.4
0.6
0.4

12332
55555
55511
53453
44542
23333
11211
45533
22121
55521
55524
15534
35531
55523
23321
15523
12312
34332
45454
55544
12321
13355
13232
13221

0.7
-0.1
0.2
0.1
0.3
0.6
0.9
0.3
0.8
0.2
0.1
0.3
0.4
0.1
0.7
0.4
0.7
0.6
0.1
0.0
0.8
0.2
0.7
0.8

12232
54334
55532
53432
44453
13222
11112
54221
22322
55522
55332
15121
25421
55544
24332
24423
12121
24433
55544
55432
12124
24332
14322
23332

0.7
0.2
0.1
0.3
0.3
0.7
0.9
0.3
0.7
0.1
0.2
0.5
0.4
0.0
0.6
0.5
0.8
0.5
0.0
0.2
0.6
0.6
0.7
0.6

1=I have no problems in walking about/washing or dressing myself/doing my usual activities/no
pain or discomfort/not anxious or depressed, 2= I have slight problems in walking about/washing
or dressing myself/doing my usual activities/no pain or discomfort/not anxious or depressed, 3=I
have moderate problems in walking about/washing or dressing myself/doing my usual
activities/no pain or discomfort/not anxious or depressed, 4= I have severe problems in walking
about/washing or dressing myself/doing my usual activities/no pain or discomfort/not anxious or
depressed, 5= I am unable walking about/washing or dressing myself/doing my usual activities/no
pain or discomfort/not anxious or depressed

Objective 3. a) The order of instances a library item was selected, from most selected to
least selected were Cherry Blossom (an afternoon stroll in the park with blooming cherry
flowers set to soft classical music) (127 times), Farm (morning walk in a farmyard with
cows and chicken set to animal and bird sound) (61 times), Truck driving (day time
simulated driving in the country roads) (34 times), Symphony (a concert playing classical
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music) (32 times), London, UK (aerial view of city streets and iconic building in London,
UK set to soft classical music) (30 times), Bavarian Alps (a morning stroll in the alpine
meadow set to bird sound) (15 times), Fishing (simulated fishing in the river set to water
sound) (13 times), Dolphin Swim club (simulated under water diving set to water sound)
(8 times), Ireland (aerial view of city streets and iconic building in Ireland set to soft
classical music) (4 times). The following library items were selected ≤3 times each; Boat
ride, Dream beach, Park, Sun and clouds, Portugal, Joy ride, and New York.
b) SDM were present in two out of 192 sessions.
c) The factors enabling participants’ VR experience included: 1) use of Broomx©
projector instead of headset, 2) the physical proximity of a familiar individual during VR
therapy sessions (KC/RA sitting beside the participant, holding his/her hand), 3) a sound
proof room with no visual distractions (e.g. windows, furniture, wall decorations), 4)
having the VR set up and running prior to introducing the resident into the intervention
area, and 5) knowledge of participants’ preferences/dislikes on VR library items. For
instance, the library item, Bavarian Alps, brought back traumatic World War 2 memories
in a participant; the water themed library items (Dolphin Swim club, Fishing, and Boat
ride) frightened a participant; and the Sun and Clouds library item reminded a participant
of her departed husband. Avoiding these themes improved their attendance at VR
sessions. Library items such as Farm and Truck Driving improved five participants’
attendance as they felt a personal connection (used to be farmers/grew up on a farm or
used to drive Harley Davidson motorcycle).
d) The factors that negatively affected the participants’ VR experience included: 1)
interrupted internet (Wi-Fi) connection, 2) VR volume too high, 3) auditory distractions
like the sound of closing doors and conversations among the staff and other residents in
the hallway, 4) participants’ conflicting schedule leading to missed sessions, and 5) a
negative emotional state of the participant (a participant missed five sessions when his
ex-wife accompanied him to the intervention area against his will. Once, the ex-wife
stopped accompanying him, he continued VR sessions).
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Objective 4. Table 3 and 4 illustrate the mean scores with SD, score difference, and
sensitivity to change of CSDD, CMAI, and proportion of night-time sleep to VR therapy.
Overall, the selected tools were sensitive to change. A small clinically meaningful change
was observed in CMAI score. CSDD score revealed a small but clinically meaningless
change. A small to moderate clinically meaningful negative change was observed in
proportion of night-time sleep. Reporting of the DOS was inconsistent with a large
proportion of missing data (>80%). We, therefore, chose not to report the results.
Table 3
Mean scores with standard deviation and pre-post score difference of the outcome
measures
Scales

Baseline
(mean, SD)

Week 1
(mean, SD)

Week 2
(mean, SD)

Change (Week Change (Week
1-Baseline)
2-Baseline)
(mean, SD)
(mean, SD)

CSDD

9.7 ± 5.3

7.5 ± 4.6

7.5 ±4.1

2.2±6.1

2.1±4.9

Mood
Behaviour

3.0 ± 1.8
2.4 ± 1.6

2.4 ± 1.9
1.8 ± 1.5

2.5 ± 1.8
1.7 ± 1.2

0.5±2.1
0.6±2.1

0.5±1.8
0.7±1.9

Physical signs

1.8 ± 1.3

1.4 ± 1.0

1.4 ± 1.2

0.4±1.3

0.5±1.4

Cyclic function

1.8 ± 1.7

1.5 ± 1.6

1.3 ± 1.3

0.4±2.2

0.5±1.7

Ideation

0.6 ± 0.8

0.3 ± 0.9

0.7 ± 1.0

0.3±1.1

0.1±1.1

53.3 ±19.1

51.3 ±21.7

48.8 ±17.2

2.3±13.4

4.8±15.2

18.8 ± 10.7

17.8 ± 9.2

16.4 ± 6.7

1.0±4.3

2.3±7.7

18.3 ± 6.3

16.5 ± 6.5

16 ± 5.8

1.8±7.1

2.3±6.5

6.4 ± 4.3

6.5 ± 4.6

5.9 ± 3.1

0.1±2.8

0.5±3.2

10.2 ± 6.3

10. 6 ± 8.2

10.7 ± 7.1

0.4±5.9

0.5±5.7

94.3 ± 9.1

88.3 ± 17.5

89.3 ± 16

5.9±13.3

5.1±10.2

CMAI
Physical
aggressive
Physical nonaggressive
Verbal aggressive
Verbal nonaggressive
Sleep

CSDD= Cornell Scale for Depression in Dementia, CMAI= Cohen-Mansfield Agitation Inventory, SD=Standard
Deviation
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Table 4
Pre-post sensitivity to change of the outcome measures, size of response, and clinical
importance
Scales

ES (Week 1Baseline)

ES (Week 2Baseline)

Response, Clinically
meaningful (at 2 weeks only)

CSDD
Mood
Behaviour
Physical signs
Cyclic function
Ideation
CMAI

0.4
0.3
0.4
0.3
0.2
0.3
0.1

0.4
0.3
0.4
0.4
0.3
0.1
0.2

Physical aggressive
Physical non-aggressive
Verbal aggressive
Verbal non-aggressive
Sleep

0.1
0.3
0.02
0.01
0.7

0.2
0.4
0.1
0.1
0.6

Yes (small)
Yes (small)
Yes (small)
Yes (small)
Yes (small)
Yes (trivial)
Yes (small), Clinically
meaningful
Yes (small)
Yes (small)
Yes (trivial)
Yes (trivial)
Yes (small to moderate),
Clinically meaningful

CSDD= Cornell Scale for Depression in Dementia, CMAI= Cohen-Mansfield Agitation Inventory, ES=Effect Size.
According to Cohen an ES is trivial if it is less than 0.20, small if it is between 0.21 – 0.49, moderate if it is between
0.51-0.79, and large if it is greater than 0.80 (Cohen, 1988). We considered the change to be clinically meaningful
when ES of CMAI score was ≥ 0.2 (Rapp et al., 2013), and ES of sleep percentage was ≥ 0.4 (Perlis et al., 2000).

Objective 5. We observed a weak association between GRC and CSDD/CMAI score
confirming our a priori hypothesis. The domain specific association revealed a moderate
association in certain domains (the behavioural disturbance domain of CSDD and the
verbal aggressive/non-aggressive domain of CMAI). However, the mean change per
domain did not equal zero when the GRC indicated no change as per our expected pattern
of association (Table 5 and 6).
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Table 5
Longitudinal validity of Cornell Scale for Depression in Dementia domains at the end of
week 1 and week 2
CSDD domain
N=24

Total score
Mood-related signs
Behavioural
disturbance
Physical signs
Cyclic functions
Ideational
disturbance

GRC-depression
Week 1
Pearson
correlation

Moderately better
(4, 5) (n=5) (mean
±SD)

Minimally better (1,
2, 3) (n=2) (mean
±SD)

Stable (0) (n=16)
(mean ±SD)

-0.23
-0.15
-0.28

6.6 ±5.5
2.4 ±2
1.2 ±1.1

6 ±1.4
2 ±1.4
1 ±1

7.5 ±4.6
2.3 ±1.9
2 ±1.6

-0.05
-0.22
0.02

4.2 ±0.5
1.2 ±1.1
0.4 ±0.9

2.5 ±0.7
1 ±0.0
0.0 ±0.0

1.4 ±1
1.4 ±1.8
0.4 ±1.0

Moderately better
(4, 5) (n=5) (mean
±SD)

Minimally better (1,
2, 3) (n=4) (mean
±SD)

Stable (0) (n=14)
(mean ±SD)

-0.16
-0.09
-0.25

5.2 ±3.3
1.8 ±1.6
1 ±0.7

9 ±3.6
2.8 ±1.7
1.5 ±1.3

7.9 ±4.5
2.6 ±2
2 ±1.4

-0.08
0.07
-0.18

1 ±1
1 ±1
0.4 ±0.9

2 ±1.2
2 ±1.2
0.8 ±1

1.4 ±1.3
1.2 ±1.4
0.8 ±1.1

Week 2
Pearson
correlation

Total score
Mood-related signs
Behavioural
disturbance
Physical signs
Cyclic functions
Ideational
disturbance

CSDD= Cornell Scale for Depression in Dementia, GRC= Global Rating of Change, SD=Standard Deviation
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Table 6
Longitudinal validity of Cohen-Mansfield Agitation Inventory domains at the end of week
1 and week 2
CMAI domain
N=24

GRC-agitation
Week 1
Pearson
correlation

Moderately
better (4, 5)
(n=2) (mean
±SD)

Minimally
better (1, 2, 3)
(n=8) (mean
±SD)

Stable (0)
(n=10)
(mean ±SD)

Minimally
worse (-1, -2, 3) (n=3) (mean
±SD)

Total score

-0.16

53.5 ±7.8

48.9 ±19.6

42.5 ±19.4

80 ±13.5

Physical
aggressive
Physical nonaggressive
Verbal aggressive

-0.15

16 ±7.1

17.5 ±10.0

16.7 ±10.4

24.3 ±4.3

0.05

21 ±4.2

17 ±7.1

14.2 ±6.6

20 ±6.3

-0.43*

5 ±2.8

5.8 ±3.4

4.7 ±3.5

13 ±5.3

Verbal nonaggressive

-0.43*

11.5 ±6.4

8.6 ±7.9

6.9 ±2.4

22.7 ±9.1

Moderately
better (4, 5)
(n=3) (mean
±SD)

Minimally
better (1, 2, 3)
(n=9) (mean
±SD)

Stable (0)
(n=8) (mean
±SD)

Minimally
worse (-1, -2, 3) (n=3) (mean
±SD)

0.06
0.08

38 ±8.5
14 ±2.7

56.8 ±13.9
18.7 ±8.0

41.3 ±15.4
14 ±5.9

58.7 ±29.6
18.3 ±8.1

0.21

12 ±2

20.1 ±5.2

12.8 ±5.2

17.3 ±5.0

0.06
-0.22

6 ±3.6
7.3 ±4.0

6.1 ±2.6
10.8 ±5.1

5.5 ±4.1
9.3 ±7.1

6 ±3.6
19 ±12.1

Week 2
Pearson
correlation

Total score
Physical
aggressive
Physical nonaggressive
Verbal aggressive
Verbal nonaggressive

CMAI=Cohen-Mansfield Agitation Inventory, GRC=Global Rating of Change, SD=Standard Deviation
*p<0.05

2.5

Discussion

Overall, this pilot shows feasibility and tolerability of VR therapy in LTC homes. Our
selected tools were sensitive to change, even given the small intervention time. Particular
domains of CSDD and CMAI had moderate association with GRC; demonstrating
longitudinal construct validity. The study recruited typical Ontario LTC population and
the researchers did not require specialization for setting up and conducting VR
stimulation therapy. Therefore, this study was pragmatic in nature and likely to be
applicable in Ontario LTC homes.
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The intervention period was only two weeks (10 sessions). Five participants missed
therapy sessions during the first week due to their conflicting schedule and health
condition. A longer (ranging between 16 sessions to 24 sessions) and flexible (seven days
a week) intervention period might have improved the compliance (Geraets., Veling,
Witlox,, Staring, Matthijssen, & Cath, 2019; Ho, Fong, Sing, Lee, Leung, Chung, &
Kwok, 2019; Park et al., 2020). Furthermore, use of headset, intermittent Wi-Fi network
and absence of a suitable intervention area also affected compliance.
We noted that participants’ sleep either deteriorated (n=12), remained the same (n=9), or
improved (n=3) during the two-week intervention period. Half (6/12) of those with
worsening sleep were prescribed psychotropic drugs such as Citalopram, Escitalopram,
and Sertraline known for causing insomnia or sleeplessness (Goncalves & Togeiro,
2912). Two thirds (2/3) of participants showing improved sleep were prescribed sleepinducing drugs (Trazodone, Mirtazapine) (Goncalves & Togeiro, 2012). Almost half
(4/9) of the participants who did not have any change in sleep were prescribed
combination drugs (Citalopram + Trazodone; and Escitalopram + Mirtazapine) known to
induce both insomnia and sleep (Goncalves & Togeiro, 2012). Therefore, we are unsure
if the use of psychotropic drugs reflects an improvement or deterioration of the
proportion of sleep.
In EQ-5D domain specific responses, we observed that participants either remained the
same (Mobility [M], n=15; Self-Care [SC], n=13; Pain/Discomfort [P/D], n=11;
Anxiety/Depression [A/D], n=10; and Usual Activities [UA], n=7), better (UA, n=12;
SC, n=8; A/D, n=8; P/D, n=5; and M, n=4), or worse (P/D, n=8; A/D, n=6; UA, n=5; M,
n=5; and SC, n=3) after the second week of intervention indicating an overall tendency
towards remaining the same. We noted that the participants with improved sleep (n=3)
also reported being better in EQ-5D-UA domain after the second week. However, those
having deteriorated sleep (n=8) also reported being better in EQ-5D-A/D (n=5), UA
(n=4), SC (n=3), and P/D (n=2) domains. Therefore, we are unsure if EQ-5D responses
agree with participants’ proportion of sleep.
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We noticed that more than half (15/24) of the participants had an improvement in CSDD
score. However, those showing an improvement in CSDD score (n=8) also reported being
worse in domain specific EQ-5D responses (A/D [n=4], UA [n=4], P/D [n=4], M [n=2],
and SC [n=2]). Furthermore, those having a decline in their proportion of sleep (n=7)
showed an improvement in CSDD score. Therefore, we are unable to declare if the
change of CSDD score reflects participants’ proportion of sleep or EQ-5D responses after
the intervention.
The CMAI domain specific changes from baseline to the end of the two-week
intervention period showed either an improvement (PNA [n=14], VNA [n=10], PA [n=9],
VA [n=8]), no change (PA [n=10], VA [n=9], VNA [n=6], PNA [n=3]), or deterioration
(VNA [n=8], VA [n=7], PNA [n=7], PA [n=5]) indicating an overall tendency towards
improved BPSD with VR therapy. On the other hand, participants having a deteriorated
sleep (n=9) had improvement in CMAI domains (PA [n=5], PNA [n=9], VA [n=5], VNA
[n=6]). We also noticed that those participants reporting being same in EQ-5D-M (n=8),
EQ-5D-SC (n=7), EQ-5D-UA (n=4), EQ-5D-P/D (n=7), and EQ-5D-A/D (n=9)
deteriorated in different CMAI domains. Thus, we cannot comment whether a change in
CMAI score matches participants’ proportion of sleep or their EQ-5D responses.
A literature review on potential benefits of VR therapy concluded that such a therapy
may provide an opportunity to enjoy leisurely activities that may promote quality of life,
psychological well-being, and social interaction in people with dementia without leaving
their home (D’Cunha et al., 2019). They located nine studies of varying study designs
and durations (D’Cunha et al., 2019). The common barriers in VR use across the studies
were confusion (n=3), discomfort associated with headset (n=2), sadness (n=1), tiredness
(n=1), and difficulty with the technology (n=1). We encountered similar barriers in our
pilot study, however we were able to propose and test solutions including using a
projector instead of a head set, consulting with SDM to help identify content most likely
to be appealing, paying particular attention to immediate reaction to VR content and
making changes as necessary, setting up the VR machine early, and using a dedicated
intervention area.
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A recent pilot randomized control trial (RCT) in older adults (71.8 ±6.6) without
dementia (n=24) used VR games with headset (30 min/day, two days/week for three
months) to explore its feasibility (Park et al., 2020). Similar to us, they declared that VR
games are feasible (adherence rate was 91.55% ±6.41%) in the VR group (Park et al.,
2020). Unlike us, they reported AE such as dizziness and fatigue during the intervention
in the VR group (Park et al., 2020). They also measured participants’ depression
symptoms with 15-item Korean version of GDS (SGDS-K [Bae & Cho, 2004]) and
reported an improvement (week 12 score-baseline score=1.1, 95% CI, -0.87 to 3.07)
(Park et al., 2020).
Another recent feasibility study in older adults (80.5±10.5) attending hospitals/day care
centers (4 centers) used one session (maximum duration was 20 minutes) of 3600 VR
video footage with headset (Appel et al., 2020). Similar to us, the participants (n=66)
were diagnosed with dementia (Appel et al., 2020). They declared VR intervention is safe
(no AE) and feasible (adherence rate was 100%, attrition rate was 0%). They measured
participants’ anxiety status with a modified version of the State-Trait Anxiety Inventory
(STAI) (Spielberger, Gorsuch, Lushene, Vagg, & Jacobs, 1983), pre-and postintervention (Appel et al., 2020). Overall, the STAI questionnaire revealed lesser anxiety
in 12 out of 16 domains (calm, relaxed, content, adventurous, energetic, happy, sad,
tense, upset/angry, worried, stressed, and anxious) (Appel et al., 2020) confirming our
findings.
A mixed-method pilot study (n=10) evaluated the effects of VR experience on the level
of engagement, apathy, and mood states of people with dementia from two LTC homes
(Moyle, Jones, Dwan, & Petrovich, 2018). The VR therapy was 15 minutes in length and
was experienced once (Moyle et al., 2018). The sensitivity to change of Person–
Environment Apathy Rating (apathy) (ES=0.1) was trivial (Moyle et al., 2018). They
evaluated participants’ engagement interviewing their caregivers (Moyle et al., 2018).
The study reported environmental distractions (noise, cluttered space) as a potential
barrier in implementing VR therapy (Moyle et al., 2018) confirming our findings.
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A feasibility study on VR therapy for people with dementia (n=57) visiting a memory
clinic asked the participants rate their VR experience (Manera et al., 2016). The
participants reported that they felt secure, comfortable, less anxious, and less fatigued in
VR environment (Manera et al., 2016), which is similar to our experience.
A case study with a 74-year-old male having mild cognitive impairment used VR therapy
with headset to evaluate any change in his cognitive status (White & Moussavi, 2016).
The participant received VR therapy (building a house in a virtual world) for 45-minutes
a day, three times per week for seven consecutive weeks (White & Moussavi, 2016). The
participant’s caregiver reported that his activities of daily living, his orientation skills
during travel, and his mood were improved during the VR therapy (White & Moussavi,
2016). The caregiver also reported cybersickness with the headset (White & Moussavi,
2016). Since our participants had no adverse event related to VR therapy, it may be
reasonable to assume that VR therapy using a projector instead of a headset is better
tolerated or that the symptom (cybersickness) is rare.
Individuals with a visual impairment and non-English speakers were not eligible for this
pilot. However, after observing our pilot participants, we felt that individuals with a
visual impairment might also appreciate the advantages of VR therapy through auditory
sensation. Further, having music/image-based VR therapy, participants need not be
capable of communicating in English to appreciate the effects.
Because of the short length of our therapy, we did not expect to observe a large change in
most individuals. Our objective was only to understand whether our proposed instruments
can detect change when even a small change has occurred. In fact, when we apply the
thresholds described by other authors (Perlis et al., 2000; Rapp et al., 2013) as clinically
meaningful, we observed a small clinically meaningful change in CMAI score and in
proportion of night-time sleep.
We found a low rate of completion for DOS scale, likely because it was not part of
regular required reporting and is conceptually difficult to complete. Therefore, we do not
recommend using this tool in a larger trial. We acknowledge that LTC homes collect
residents’ health related data using Resident Assessment Instrument-Minimum Data Set
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(RAI-MDS) 2.0 as part of their usual reporting to guide their care planning and
monitoring (Hutchinson et al., 2010). The RAI-MDS 2.0 collects residents’ data on
accidents, behavioural and emotional patterns, clinical management, cognitive patterns,
elimination and continence, infection control, nutrition and eating, physical functioning,
psychotropic drug use, quality of life, and skin care (Hutchinson et al., 2010).
The RAI-MDS 2.0 components for evaluating BPSD are 1) the Depression Rating Scale
(DRS) and 2) the Aggressive Behaviour Scale (ABS) (CIHI, 2010b). The DRS evaluates
depression using seven items (negative statements, persistent anger with self or others,
verbal/non-verbal expressions of unrealistic fear, repetitive health/ non-health complaints,
sad/pained/worried facial expression, and crying/tearfulness) scoring 0 to 2 (0=no
symptoms in last 30 days, 1=symptoms present five days a week, 2= symptoms present
six/seven days a week) (Burrows, Morris, Simon, Hirdes, & Phillips, 2000). The scale
adds all seven items to provide a final score where 0 indicates no symptoms, 3 indicates
mild depression, and 14 indicates major depression (Burrows et al., 2000). The DRS is
reliable (α=0.69) and valid (correlation with CSDD [r=0.69, p<0.01] and Hamilton
Depression Rating Scale [Hamilton, 1960] [r=0.70, p<0.0] is strong) (Burrows et al.,
2000). The ABS has four components (verbal abuse, physical abuse, socially disruptive
behaviour, and resistance of care) with a score range from 0-12 (higher scores indicates
greater frequency and diversity of aggressive behaviour) (Orpinas & Frankowski, 2001).
The scoring of ABS is based on seven days’ observation of residents where each item is
scored from 0 to 3 (0=no symptoms, 1=symptoms observed 1-3 days in the past 7 days,
2=symptoms observed 4-36 days in the past 7 days) (Orpinas & Frankowski, 2001). The
tool is reliable (α=0.8) and valid (correlation with CMAI is strong, r=0.72, P<0.01)
(Perlman & Hirdes, 2008). The Ministry of Health and Long-Term Care recommends
using RAI-MDS 2.0 in Canadian LTC homes (CIHI, 2010b). We suggest using RAIMDS 2.0 in future studies to measure BPSD of Ontario LTC residents to avoid
redundancy.
Limitations. The participant recruitment depended on communication with their SDM.
The recruitment phase was short (around six weeks) and required us to reach the SDM
during their occasional visit to the Henley Place or over the phone only during weekdays
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from 9 to 5pm. In a fully funded study, with greater resources to allocate to recruitment
efforts, we expect recruitment rates to improve.
The clinical utility of the CSDD is highly questionable in identifying depression when
administered by LTC staff because of the complexity of the scale, the time and skills
required for collecting data, and knowledge of assessing depression (Jeon et al., 2015).
Further, the creators of the CSDD recommend standardized training, which reduces its
utility in a practice setting.
Overall, our study was biased inherent to the study design. For example, absence of a
control group impaired our ability to report whether changes in outcome reflected the
therapy or simply the ups and downs associated with dementia progression.

2.6

Conclusion

VR therapy is feasible in Ontario LTC homes and residents with moderate to severe
dementia might tolerate such therapy. The sensitivity to change of the selected tools
(CSDD and CMAI) indicated that VR therapy might have a role in reducing BPSD in the
population of interest. However, we are not confident of the precision of these estimates
because this was a small pilot study. Considering the burden of BPSD on older adults
with dementia and their caregivers, VR therapy is a possible non-pharmacotherapy in
managing BPSD in LTC homes.
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Chapter 3
3

Understanding informants’ perspectives on use of virtual
reality therapy for older residents with dementia in a longterm care setting: An interpretive description

3.1

Summary

BACKGROUND: I used the interpretive description approach to understand observers’
perspectives on the use of virtual reality (VR) therapy for residents diagnosed with
moderate to severe dementia in a for profit long-term care home (LTC) setting (192 beds)
in mid-size city in southwestern Ontario, Canada. Interpretive description refers to a
constructivist qualitative research approach that is used to develop a deep understanding
of subjective experiences of practical importance in health science. METHOD: The
informants included family members of the residents participating in a pilot study of VR
as possible cognitive stimulation therapy, LTC staff, and VR pilot researchers. I
conducted a series of semi-structured interviews and analyzed interview transcripts
thematically. RESULTS: Four themes emerged from the informants’ subjective accounts:
1) a noticeable change in the residents, 2) implementation challenges of VR therapy in a
LTC setting, 3) uniqueness of the VR therapy, and 4) duration of VR effect. Overall,
informants reported that they perceived VR therapy induced a positive “change” in
residents’ behaviours. CONCLUSION: The residents were perceived as relatively
calmer, happier, more relaxed, better in eating and in communicating than usual
throughout the intervention and follow up. All of the study informants felt VR therapy
could be offered on a regular basis to residents with dementia in LTC settings.

3.2

Objective

A pilot study of VR therapy was conducted during November 2018-January 2019. The PI
of the pilot invited my supervisor (DB) and I to one of their post-pilot meetings because
we wanted to learn more about their intervention (VR therapy). Pilot researchers
mentioned several noticeable changes in the participants during and after the VR therapy,
previously not identified as possible outcome. I realized that a qualitative inquiry might

36

unlock previously unknown effects of VR therapy useful for future clinical interventions
for persons living with dementia.
The objective of the current study was to explore the experiences of informants (i.e.,
family members, staff members, and pilot researchers) of pilot participants (i.e., residents
with moderate to severe dementia in LTC) who completed VR therapy in the pilot study.
The qualitative inquiry was conducted three months (April 2019) after the pilot study. For
the purpose of clarity of reporting, I referred herein to the interviewees in this qualitative
study as “informants”. I referred to the participants with moderate to severe dementia
who completed the pilot study of VR therapy as “residents”. I used the term
“investigator” to describe any researcher other than the informants to avoid confusion.
The participants of the pilot study were LTC residents with dementia exhibiting BPSD
and the pilot intervention was VR experience provided with Broomx© (Broomx
Technologies, 2019). BroomX© provides VR experience with the help of a projector
connected to a smart phone app on a frameless screen (a room) (Broomx Technologies,
2019). Pilot participants experienced images such as Cherry Blossom (an afternoon stroll
in the park with blooming cherry flowers set to soft classical music), Farm (morning walk
in a farmyard with cows and chicken set to animal and bird sound), Truck driving (day
time simulated driving in the country roads), Symphony (a concert playing classical
music), London, UK (aerial view of city streets and iconic building in London, UK set to
soft classical music), Bavarian Alps (a morning stroll in the alpine meadow set to bird
sound), Fishing (simulated fishing in the river set to water sound), Dolphin Swim club
(simulated under water diving set to water sound), Ireland (aerial view of city streets and
iconic building in Ireland set to soft classical music). Boat ride (a simulation of riding a
boat along the river), Dream beach (image of sandy beach), and Sun and clouds (image of
daytime sky).

3.3

Choice of study approach

I conducted 15 semi-structured interviews for this study based on my paradigm position
(constructivism) using interpretive description approach (Thorne, 2016) for data
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collection and analysis. The next sections address the rationale for the selected study
approach.
In the 1960s and 1970s, a reformist movement named qualitative inquiry challenged the
idea of a single truth and introduced the idea of multiple realities in the philosophical
pursuit of knowledge (Carpenter & Suto, 2008). Unlike quantitative research, like that
used in the pilot VR therapy study, qualitative research captures the unique elements of
experiences, thoughts, and feelings of the individuals being investigated (Peck &
Mummery, 2018).
Social sciences (e.g., anthropology, sociology, and psychology) generated a range of
methodologies (e.g., ethnography, grounded theory, phenomenology, etc.) to conduct
qualitative research relevant to their disciplinary projects (Hamilton, 1994; Vidich &
Lyman, 1994). However, qualitative methods adopted in social sciences do not always
meet the criteria of pragmatic research of health sciences despite an intellectual
agreement that there exist multiple subjective realities (Stajduhar, Balneaves, & Thorne,
2001). While social sciences capitalize on health phenomena to answer elemental
questions related to core features of human experiences, health sciences pay attention to
solving everyday health and wellness issues of individuals or to understanding the effect
of a particular health intervention (Alasuutari, 2010).
Scholars within social sciences pay rigid attention to methodological tradition for a
credible qualitative research design (Sandelowski, 2014). The tensions between
theoretical integrity in social sciences and real-world utility in health sciences compelled
me to adopt a methodological entity suitable for health sciences, referred to as
interpretive description (Thorne, 2016; Thorne, Reimer Kirkham, & O’Flynn-Magee,
2004; Thorne, Reimer Kirkham, & MacDonald-Emes, 1997).
Interpretive description is not a novel or distinctive approach but rather an adaptation of
available design techniques suitable to answer a health research question regardless of
methodological eclecticism (Thorne, 2016). Therefore, the approach used cannot be
labelled as a methodology (Thorne, 2016). However, interpretive description is not a
simplistic study free from theoretical or disciplinary underpinnings (Kahlke, 2014). The
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approach allows health investigators to organize their study design around their
disciplinary conceptual and epistemological frame (Thorne, 2016).
The philosophy and research methods in qualitative research are intertwined, meaning a
particular philosophy usually implies the use of a particular method (Finlay, 2006). The
enquirer of a qualitative research is guided by a set of basic beliefs (paradigm), not open
to proof (Lincoln & Guba,1994). Paradigms guide the design framework of a qualitative
study based on four principles including epistemology or the nature of knowledge,
ontology or philosophical stance, methodology or strategy that links methods to
outcomes, and methods or techniques to produce data (Creswell, 2007).
According to Lincoln and Guba (1994), the epistemology and ontology of constructivist
paradigm are transactional/subjectivist (knowledge is co-created by the investigator and
the informants as the investigation proceeds) and relativism (realities are multiple mental
constructions based on informants’ social interactions and/or experiences and are
subjective in nature) respectively. However, the conventional distinction between
epistemology and ontology disappears in constructivist paradigm (Lincoln & Guba, 2013;
1994). The epistemological and ontological position in constructivist health research
often is most closely aligned with interpretive approaches (where there is a focus on
understanding human behaviour/perceptions instead of explaining them) (Green &
Thorogood, 2018). I realize that the VR therapy effect on residents is open to informants’
subjective multiple interpretation and my reconstruction of their interpretation. Therefore,
I positioned myself in constructivist approach.
According to Lincoln and Guba (1994), the methodology in constructivism is
hermeneutical and dialectical. Hermeneutics refers to the theory and practice of
interpretation (Paterson & Higgs, 2005). The term is derived from Hermes, the messenger
from Greek mythology, who acted as interpreter between the gods and mortals (MerriamWebster, 2020a). The term, “dialectic” refers to understanding a phenomenon by
dialogue as a method of intellectual investigation (Merriam-Webster, 2020b). The
hermeneutical and dialectical methodology accepts the inclusion of the investigator in the
data-collecting process (Rychlak, 1996).
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In health sciences, hermeneutical and dialectical approaches involve listening carefully
and thoughtfully to informants’ perspectives (Johnson, 2015, 2012). It also involves
combining important ideas/values of both investigators and informants into a construct
useful for answering the research question(s) (Johnson, 2015, 2012). Moreover, it
includes facilitating understanding, dissemination, and use of research findings (Johnson
& Schoonenboom, 2016). Finally, it involves continually evaluating the research findings
relevant to the stakeholders (Johnson & Schoonenboom, 2016).
My informants did not experience VR therapy, rather they observed the VR study
participants (i.e., residents). Their accounts were based on their observations,
experiences, and perceptions shaped by their relationship with the residents, their
professional stances, and their subjective values. I wanted to explore an actual real-world
question (what are the experiences/observations/perceptions of individuals with VR
therapy positioned to observe pilot participants?) and to appreciate the conceptual and
contextual realm within which the informants were positioned. Therefore, I declare my
approach to be hermeneutical and dialectical in congruence with health sciences.
To understand the usefulness of the inquiry, I searched databases such as PubMed,
Scopus, Psych Info (search phrase was virtual reality AND dementia AND qualitative
research with no limiting criteria) and retrieved 12 papers (qualitative inquiry [n=10],
review article [n=2]). Out of 10 qualitative inquiries, one was a conference proceeding,
one was written in Spanish language, one did not use VR as intervention, and one used
VR intervention for family caregivers. One of the members on my Doctoral Advisory
Committee (JBO) provided me with one related study (Appel et al., 2020). Based on
these papers (Appel et al., 2020; Baker et al., 2020; Ferguson, Shade, Boron, Lyden, &
Manley, 2020; Rose, Stewart, Jenkins, Tabbaa, Ang, & Matsangidou, 2019; Moyle et al.,
2018; Martinez-Pernia et al., 2017; McEwen, Taillon-Hobson, Bilodeau, Sveistrup, &
Finestone, 2014), I concluded that an inquiry into caregiver and family’s perception of
the VR experience was likely to produce new and necessary information about VR
therapies (Table 7: Available qualitative research on virtual reality and dementia
published in English). I also learned that no other peer-reviewed published qualitative
inquiries currently exist on VR therapy with BroomX©
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(http://www.broomx.com/broomxvr.php ) in LTC residents with moderate to severe
dementia.
Based on my clinical and academic research interests (what was the observed change in
pilot participants) and my understanding of what is already “known” through the related
published literature (a need for an inquiry into caregiver and family’s perception of the
experience) (Ferguson, Shade, Boron, Lyden, & Manley, 2020), I believe 15 semistructured interviews to explore the subjective accounts of the informants adopting an
interpretive description approach (Thorne, 2016) is appropriate to produce meaningful
answer to my research question.
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Table 7.
Available qualitative research on virtual reality and dementia published in English
Reference

Participants

Intervention

Method

Results

Implications

Appel et al.,
2020

Older adults
with cognitive
impairment
(n=66)

Single visit
20-minute
nature scene
provided with
headset

Mixedmethod study

Caregivers reported
participants being
more relaxed during
the experience

Baker et al.,
2020

Residential aged
care facility
members (n=5)
and staff (n=5)

Two-week
virtual
experience
with headset

Qualitative
interviews

Virtual experience
can play a role in
engaging residents
who might otherwise
self-isolate

Ferguson,
Shade, Boron,
Lyden, &
Manley, 2020

Hospice patients
living with
dementia (n=25)

A single visit
30-minute
YouTube
Video of a
beach scene
using a
headset

Narrative
inquiry

Rose, Stewart,
Jenkins,
Tabbaa, Ang,
&
Matsangidou,
2019

People with
mild to
moderate
dementia (n=8)
living in an
inpatient
Psychiatric Care
setting
People with
dementia (n=10)
from two longterm care (LTC)
homes, their
family members
(n=10), and
LTC staff (n=9)
Clinicianpatient dyad
(n=16)

Virtual
experience (5
still images)
for 15
minutes, once
a week for
two weeks
with headset
One session
of a single
virtual image

Mixedmethod study

Four themes:
narration
(commented about
their experience),
affirmation (enjoyed
or was appreciative
of the experience),
comfort level
(headset too tight,
headache, dizziness,
nausea), and
unfulfilled (was
bored watching the
same scene for a
long time)
The participants had
a positive virtual
experience and
described their
experience as a good
“change in
environment”

The technology is
feasible. However, a
better picture quality
and an accompanying
audio file may improve
the experience
The technology is
feasible. Headset can
create a potential
negative impact on
those living with
dementia
Realization of a need
for a devise for
comfortable
experience, and an
inquiry into caregiver
and family’s perception
of the experience

Mixedmethod study

Virtual experience
improved the
awareness and mood
of people with
dementia

Setting up the machine
was time consuming
and needed clutter free
space. Keeping
participants engaged
more than 10 minutes
was challenging

A simulated
game (making
tea)

Case study

Users accepted the
technology

A person with
dementia and
his caregiver

1 hour driving
simulation, 5
days a week
for 2 weeks
provided with
a headset

Case study

Caregiver reported
the user being
attentive to his daily
activities. However,
the headset agitated
the user

The technology can be
used as a
neuropsychological
assessment tool
People with dementia
may tolerate this
technology

Moyle, Jones,
Dwan, &
Petrovich,
2018

MartinezPernia et al.,
2017
McEwen,
TaillonHobson,
Bilodeau,
Sveistrup, &
Finestone,
2014

Realization of a need
for a wide variety of
images to keep the
participants engaged
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3.4

Method

3.4.1

Informants

Thorne (2016) pointed out that individual interviews involving multiple people under
multiple circumstances are useful to gain insight into a clinical issue. I recruited family
members, LTC staff, and pilot researchers as informants for this study because I was
interested in understanding the phenomenon from multiple opposing/endorsing accounts.
I was cognizant of the concept of epistemic injustice, conversations and dementia
(Young, Lind, Orange, & Savundranayagam, 2019), thus reflected carefully on including
the interviews residents who completed the pilot VR intervention study. However, the
residents’ moderate to severe cognitive status prevented their ability to provide a direct
account of their observations/experiences with VR.
Sorting out whose voices were listened to and who gets to determine what those voices
intended require careful considerations in qualitative inquiry (Salter, 2013). In a
qualitative inquiry, therefore, it is assumed that every voice is unique and none have full
comprehension of the topic of interest (Thorne, 2016).
For this current qualitative study, family members of the residents knew their loved ones
and were familiar with their typical demeanor long before their family members started
living inside this facility. Each family member informant was focused on his/her family
member for the purpose of the current study. As such, each family member informant
was positioned to describe any subtle change in his/her family member before, during,
and after VR therapy.
Staff members (e.g., PSW, nurses, administrators) had opportunities to observe the
residents in their everyday life, their health conditions, their transfers to-from hospital
emergency departments, their convalescences, before and after their outings with their
family, and before and after their VR therapy. PSW cared for the same residents for
years, while nurses and administrators were familiar with all participants, their cognitive
status, and their health and medical conditions. Therefore, staff members were wellpositioned to comment on residents’ presenting responses (good or bad) to the VR
therapy.
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The pilot researchers were in a unique position. They observed the residents throughout
the VR therapy because they sat by them during the whole duration. Thus, they had
sufficient opportunities to observe any effect of VR therapy on the residents.
3.4.2

Recruitment

I approached the PI of the pilot VR therapy study to identify possible informants
following the protocol approved by local ethics board (See Appendix B for ethics
approval). The eligibility criteria I used to identify possible informants were 1) family
members who visited the participating residents either before, during, or after VR therapy
sessions; 2) staff members who were included in participating residents’ care circle either
before, during, or after VR therapy sessions; and 3) researchers who implemented the
pilot study.
After receiving the contact information of the possible informants (family members
[n=24], staff [n=7], researchers [n=3]) from the pilot study PI, I contacted the informants
by telephone calls, e-mail, or in-person. I did not, however, contact family members of
deceased participants (n=3) to avoid causing any pain while remembering their loved
ones or their responses to the VR therapy. Five of the twenty-four family members
agreed to participate in an interview. The reasons for declining the interview included: 1)
not being able to observe their loved ones during the pilot study, thus considering not
being useful for the inquiry (n=7), 2) being away from the study site area during this
inquiry (n=5), and 3) inability to accommodate an hour for the interview (n=4).
The study site had restrictions on sharing their staff’s personal contact information. I
recruited staff informants at their workstation during their lunch break. Five out of seven
staff’s work schedule was busy. LTC administration agreed to cover one hour of their
work schedule with another staff. Thus, all contacted staff (n=7; PSW=6, nurse=1)
participated in this qualitative inquiry. All three VR pilot researchers agreed to
participate. One of the researchers also was appointed as an administrator at the study
site. The purposive sample size was 15. Any sample size is acceptable to conduct
interpretive description (Thorne, 2016). I considered the subjective accounts from the 15
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informants from three diverse backgrounds to be adequate to achieve the objectives of the
study.
3.4.3

Interviews

I interviewed the informants during the month of May (7-27) of 2019. They provided
written consent for the interviews (See Appendix C for consent form). Since this study
was an amendment to the earlier pilot, I applied to the same ethics board for approval. I
disclosed my constructivist position as an investigator and my affiliation with Western
University prior to each interview. I conducted the interviews in a manner that was open
and where questions did not lead the informants to provide specific types of information
(See Appendix D for the interview question guide).
I conducted the one on one interviews in a quiet room away from the residents’ living
area inside the LTC. Each interview was approximately one-hour duration. I
acknowledge that I am not a native speaker of English and that I am not in the position to
understand the full spectrum of contextual Canadian vocabulary. I immigrated to Canada
ten years ago. Therefore, I requested that the informants repeat their words and to clarify
what they meant in cases where they used phrases, idioms and culturally dependent
words during the interviews. I did not interrupt any informant while he/she was speaking
and left larger gaps for them to continue speaking following Green and Thorogood’s
(2018) recommendations. I recorded all interviews to optimize the accuracy of data
collection. Two audio-recorders (TASCAM digital voice recorder, DR-05V2 170620 and
Sony Digital Voice Recorder, ICDUX560BLK) were used at the same time to avoid
accidental loss of interview data from any unforeseen technical difficulties.
The interview started with an open-ended question enquiring about the informant’s
perception on residents’ experiences with the VR therapy. I engaged with the informants
using prompts where necessary (e.g., explaining more fully changes in the resident’s
behaviours).
I initially listed several (n=43) behaviours as “positive” and “negative” based on the
Need Driven Behaviour Model (Algase et al., 1996) and LTC home staff experiences
(please refer to Chapter 2 of this thesis), in case the informant sought clarification. I

45

learned during the first two interviews that the labelling of “positive” and “negative” was
not exhaustive. Consequently, I refrained from using this prompt during the remaining
interviews and let the informants describe their perceptions of residents’ behaviour in
their own words.
I invited a doctoral student to listen to and to comment on the audio recordings (n=15)
immediately after completion of each interview to help me use prompts to elicit
meaningful information from future informants. For instance, the doctoral student pointed
out that when I was prompting an informant using the term, “behaviour change”, it might
have limited the informant’s response. The meaning of the term, “behaviour change” can
vary among individuals. From then on, I avoided using the term, “behaviour change”.
Instead, I requested the informant to describe his/her perceptions related to VR therapy
worth sharing.
I saved the audio files with a unique code and stored in an encrypted Google Drive folder
in keeping with the approved ethics protocol for data security. A professional
transcriptionist transcribed orthographically and verbatim each interview. Only the
transcriptionist and I had access to the audio files. I reviewed the transcript data against
the audio data word-for-word. No revisions were required.
3.4.4

Observations

The challenge for a clinical investigator in health science is to be aware of one’s
particular professional lens (Thorne, 2016). One way to overcome this challenge is to
challenge oneself continuously to consider what other explanation might be out there
with the help of other forms of data to help understand what one is
observing/experiencing (Thorne, 2016).
To understand the contextual environment of a LTC home, I paid attention to the
surrounding physical, cultural, and emotional settings. I recorded in writing in field notes
my interpretations of the LTC home environments (i.e., physical and social), social
interactions among the staff members and residents, and my communication (verbal and
non-verbal) with individuals irrespective of their relationship to the research question
during the overall study.
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In the field notes, I recorded aspects of non-verbal communication such as nodding,
gesturing, frowning, and facial expression during the interviews. Writing field notes was
possible while interviewing because of the digital audio recordings. I also wrote down
informants’ comments related to VR therapy outside the interview recording period (e.g.
conversation during recruitment period, before and after recording of the interviews). I
constantly checked my field notes against the interview data to reflect on any other
possible interpretation of my initial understanding.
3.4.5

Quality of data

The concept of validity and reliability in quantitative research cannot be applied in the
same way as in qualitative research (Leininger, 1994; Thorne, 1997). The established
qualitative research methodologies (e.g., ethnography, grounded theory, phenomenology,
and narrative inquiry) consider criteria such as credibility, confirmability, meaning
context, recurrent patterning, saturation, transferability, trustworthiness, transferability,
and dependability to establish worthwhile data (Guba & Lincoln, 1989; Leininger, 1994;
Lincoln & Guba, 1985, 1994). According to Thorne (2016), the evaluative criteria for
data quality typical in interpretive description are 1) epistemological integrity, 2)
representative credibility, 3) analytic logic, and 4) interpretive authority.
Epistemological integrity. To achieve epistemological integrity, the research question
must be consistent with the stated epistemological standpoint and the interpretation of
data sources must follow that question (Thorne, 2016). My research question invited
multiple co-constructed truth. My data interpretations were rooted in my constructivist
stance to attain epistemological integrity.
Representative credibility. Representative credibility can be achieved by sampling
individuals positioned to observe/experience a phenomenon from multiple angles of
vision (Thorne, 2016). I invited three groups (family, staff, researchers) for interviews
who were positioned to observe the residents who participated in the VR pilot study from
multiple perspectives. In that way, I achieved representative credibility (i.e., multiple
perspectives and validation of data from different informants positioned to perceive a
phenomenon from different fields of vision).
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Analytic logic. A qualitative investigator can never assure the reader of an exhaustive
inductive reasoning (Morse, 1994). Instead, evidence of a sufficiently visible inductive
reasoning throughout the work enabling the reader either to confirm or to reject its
credibility can be labelled as analytic logic (Thorne, 2016; Morse, 1994). In health
sciences, intellectual audit trails (i.e., investigator reflects on how his/her thinking
evolved throughout the work) and/or thick description (i.e., grounding interpretive claims
in verbatim accounts/illustrative material visualizing the context) often are used to
achieve analytic logic (Carcary, 2009; Koch, 2006; Ponterotto, 2006; Sandelowski,
1986). I described my reflections throughout the work to acquire intellectual audit trails
and presented relevant verbatims to capture thick description, ultimately to achieve
analytic logic.
Interpretive authority. Reflexive accounts of the investigator revealing his/her own
biases or experiences to help the reader separate the subjective truth from the shared truth
can achieve the interpretive authority (Altheide & Johnson, 1994; Paterson, 1994;
Schwandt, 1996). I attempted to achieve sufficient clarity by aiding the readers to
distinguish my constructs from co-constructs which, in turn, helped attain interpretive
authority. To achieve reflexivity, I presented my personal experience related to the
contextual meaning of my interpretation throughout the text.
Thorne (2016) suggests an additional set of criteria for health sciences. They are, (1)
moral defensibility (whether the knowledge potentially benefits the population of
interest), (2) disciplinary relevance (whether the knowledge is appropriate for the
intended discipline), (3) pragmatic obligation (whether the knowledge is usable for
practice discipline), (4) contextual awareness (whether the knowledge recognizes the
contextual realities), and (5) probable truth (whether the knowledge is of considerable
value until rejected with compelling reasons). I followed these criteria to assist my
reflections on the research question, to support my interpretations of subjective accounts,
and to advance my understanding of possible implications from the data and my
interpretations.
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3.4.6

Data analyses

The potential hazard in qualitative data analyses is to create patterns out of pieces of
information (e.g., words, gestures), already hardwired in our minds (automatically
thinking in a particular way), as being meaningful (Thorne, 2016). In interpretive
description, the investigator must see beyond the obvious, rigorously deconstruct his/her
own understanding of data, and take ownership over the potential meaning and impact of
the interpretation of subjective constructs (Thorne, 2016). What I consider meaningful is
based on my personality, experiences, disciplinary orientation, biases, and curiosities.
Therefore, I invited another doctoral student (MJ) from another disciplinary orientation
(Physiotherapy) to analyze independently the transcript data. I discussed my
interpretation with her to understand if I am missing any construct or interpreting any
construct differently. MJ, however, did not use my field notes when analyzing the
transcript data to avoid being biased from my reflections and to help me see beyond my
perceptions following Thorne’s (2016) work.
According to Bailey (2008), relying entirely on transcript data is a potential risk of losing
insight arising from the nuances, pauses, tone and deliverance of informants’ discourse. I
used the recorded interviews, transcripts, and my field notes when analyzing the data to
avoid this potential pitfall. I used NVivo© software (QSR International Incorporation,
2019) to help me organize the data.
I used thematic content analysis approach defined as “a method for identifying, analyzing
and reporting patterns within data” (Braun & Clarke, 2006, p. 79). Thematic content
analysis allows a rich, detailed and complex description of data without following a
certain theoretical framework (Braun & Clarke, 2006), applicable for the current study (I
did not follow any theoretical framework). This type of analysis is a useful method for
examining the perspectives of different research informants, generating unanticipated
insights, and summarizing key features of a large data set (Braun & Clarke, 2006) and is
frequently used in interpretive description approach (Thorne, 2016).
Although there are many advantages to using thematic analysis, I must also acknowledge
the disadvantages of this method. The main disadvantage of thematic analysis is its
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flexibility that can lead to inconsistency and incoherence when developing themes
derived from the research data (Holloway & Todres, 2003). My explicit epistemological
position (constructivism) aided consistency and cohesion in thematic analysis following
the recommendation of Holloway and Todres (2003).
3.4.7

Sorting and organizing data

Thorne (2016) cautions against overenthusiasm for data management software as these
software programs may overshadow an investigator’s intelligence and inductive thinking.
I initially coded the texts as a single unified data set. (i.e., sentences/paragraphs instead of
words) based on their relatedness to an idea (e.g., dementia as a condition, observed
BPSD in residents, events consequential to those symptoms, emotions attached to those
events, perception of VR/VR therapy, experience with implementing the pilot, etc.). My
objective was to understand the experiences of the informants rather than understanding
what the experience meant to certain group of informants or why they explained the
phenomena as they did. Therefore, a unified dataset derived from interview transcripts
and field notes was appropriate.
I used NVivo© software to select sentences or sections of the text data as codes. After
coding the texts, I organized the relevant codes into nodes based on their relatedness with
each other, my interpretation of those utterances, and emotional/cultural/behavioural
constructs attached to them recorded in my field notes. NVivo© software permits a user
to create a separate file called nodes (QSR International Incorporation, 2019). Nodes
refer to a collection of codes about a specific topic and related other forms of data (QSR
International Incorporation, 2019). I also recorded my reflexive accounts from my field
notes in marginal memos (a feature offered in NVivo© software that connects files with
the nodes).
3.4.8

Making sense of pattern

The ultimate goal of thematic analysis is to make sense of what relationships the various
groups of data pieces might possibly have to one another and inductively build some sort
of meaningful construct (Malterud, 2012). Thematic analysis in health sciences involves
an iterative reasoning process to gradually come to understand the implications of
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constructs and to align investigator’s own ideas with those constructs (Miles &
Huberman, 1994).
Keeping in mind the objective of this inquiry, I identified which nodes addressed similar
ideas and aligned my reflexive notes with those nodes to create “parent nodes”. NVivo©
identifies a cluster of nodes as “parent node” (QSR International Incorporation, 2019).
For example, those nodes describing the VR library items, what was so special about
them, and how they impacted a resident were grouped as “library items” parent node. I
reviewed and refined the “parent nodes” based on my perception.
I first visualized a pattern of ideas as they unfolded through nodes (in this case, parent
nodes) following Thorne (2016). I read those “parent nodes” identified by MJ to help
myself perceive the pattern of ideas in a different perspective and to understand other
possible organizing options. I realized that some “parent nodes” shared a central idea
(theme) but expressed different contextual meaning or had other aspects worth paying
attention to. I labelled them as “sub-themes”.
3.4.9

Transforming pattern into themes

A theme gives meaning to data and helps to understand the "big picture" as per the
investigator's judgement (Braun & Clarke, 2006). Themes in interpretive description are
rigorously thought-through conceptualizations of data patterns focused on the objective
of the study (Thorne, 2016).
I read and re-read the entire dataset to understand whether the pattern of ideas I identified
reflected the larger dataset and whether they were related to the study objectives. In that
way, I recognized several themes (n=6). My iterative process of transforming patterns
into themes is presented in Figure 3 (Data analysis process). I invited MJ to review
critically the themes I identified against the themes she identified. Her comments made
me realize that my interpretations were comparable to her interpretations. However, her
perspective on certain themes (n=2) were different than my point of view. I re-evaluated
the relationships of the themes and revised them accordingly.
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Figure 3. Data analysis process.

3.5

Results

After critically sorting and organizing data, MJ and I identified 56 nodes and 19 parent
nodes (Table 8: Sorting and organizing coded data) before collapsing them into four
themes focused to the objective of this inquiry (experience with VR therapy). The four
themes include 1) a noticeable change in the residents, 2) implementation challenges of
VR therapy in a LTC setting, 3) uniqueness of the VR therapy, and 4) duration of VR
effect. A selection of supporting quotes for each theme are outlined in Table 9. I
identified six sub-themes sharing the theme, “a noticeable change in the residents” (Table
10) and seven sub-themes sharing the theme, “implementation challenges of VR therapy
in a LTC setting” (Table 11).

52

Table 8
Sorting and organizing coded data
Themes (n=4)

A noticeable
change in the
residents

Parent nodes
(n=19)
(Sub-themes)
Communication

Demeanor

Being relaxed
Attention

Being active

Eating behaviour
Implementation
challenges of VR
therapy in a LTC
setting

Library items

Duration of
therapy
Flexibility
Staff dependency

Staff commitment

Therapy area

Technical issues

Uniqueness of
the VR therapy

Almost real,
suggestions for
future

Duration of VR
effect

Is there a longterm effect?

Nodes (n=56)

Interacting with other residents and staff, finding words,
showing caring side of their personality, spoke in a positive
way, able to carry on conversation longer, listens to the
conversation, responds better
Stopped rubbing hands, calling out less, smiling more, more
understanding, listening to radio again, played with grandson
again, started noticing her stuffs brought from home
Completing 30-minute session, less restless, falling less,
sleeping during the therapy
Paying attention to virtual reality (VR) images, paying
attention to surrounding environment, paying attention to the
researcher
Willingly dressing themselves in nicer outfits, not resisting
baths, taking care of their personal belongings, coming out of
the room more often
Eating better, not eating while wandering, eating being seated
Responded to familiar images, specific images brought back
negative memories, tailoring library item, confusion regarding
space and time
Duration of therapy needs to be longer, therapy effect
depended on duration of therapy, can be a regular therapy
Schedule needed to account for regular activities, therapy
schedule needed to account for residents’ mood
Staff education on VR therapy, staff are overwhelmed, staff
involvement in measuring pilot outcomes
Willingness to maintain VR machine, willingness to learn how
to operate VR machine, time commitment to conduct VR
therapy
A dedicated therapy area, setting VR machine at residents’
room is impractical, VR machine setting time upset residents,
background noise interrupted resident’s attention
Use of a headset was impractical, disinfecting protocol for
headset was time consuming, interrupted internet (Wi-Fi)
connection, VR app control
Feels so real, treated patients as a person, can be a recreational
activity

A lingering effect for months, reverted back to old self after
therapy stopped, not sure if the effect was due to VR
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Table 9
Themes with supporting quotes
Theme

Key supporting quote

A noticeable
change in the
residents

“Resident X’s son really noticed a difference with his mom because he
was able to sit and have a conversation with her. Before she wouldn’t sit.
She would not sit for five seconds and now she’s sitting and she’s talking
about cows.” (S-4)

Implementation
challenges of VR
therapy in a LTC
setting

“The other challenge that we had was all the paperwork and
questionnaires… it was a lot of paper trail and expectations for the staff
or one of the behaviour mod staff to assist us with those questionnaires.”
(R-3)

Uniqueness of the
VR therapy

“It was individual, it was about them, it was special.” (S-3)

Duration of VR
effect

“There was sort of an after effect, a lingering effect, that occurred.
People were calmer and more focused. The dietician commented on
somebody we would feed sandwich to while they were wandering, …
She said when the VR stopped that resident continued to be able to sit at
the table and eat.... so that’s a big difference there and it didn’t just stop
when the VR stopped.” (R-2)

S=Staff informant, R=Researcher informant
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Table 10
Sub-themes with supporting quotes for Theme 1: “A noticeable change in the residents”

Sub-theme

Supporting quotes

Communication

“He’d say I’m doing good but before I couldn’t understand what he was
saying.” (S-7)

Demeanor

“her calling out wasn’t as much when she was doing the virtual reality, but
then after it seems like it increased.” (S-1)

Being relax

“Cherry blossom was a good one because it was a lot of family and dogs
and parks and colors. So, they would point, they would verbalize.
Sometimes they would drift off to sleep and I wouldn’t wake them up and if
I changed the experience or the music changed, they would rattle around
and wake up and then re-engage in the experience”. (R-3)

Attention

“I noticed that he was actually paying more attention to that picture with
him and his wife because never before would he look at it.” (S-7)

Being active

“I’ve seen her out of her room more.” (S-4)

Eating behaviour

“Before the VR she was very restless, she walked around all the time, she
didn’t sit to eat, we fed her while she walked. During the VR process she
sat in the meals, she had weight gain.” (S-5)

S=Staff informant, R=Researcher informant
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Table 11
Sub-themes with supporting quotes for Theme 2: “Implementation challenges of VR
therapy in a LTC setting”
Sub-theme

Supporting quotes

Library items

“Resident X is on the secure unit and he always wants to go home.…
So, we got him in there, and he sat down, and he said where are we
going, and I said where do you want to go? He said, I want to go to
Belmont. I said okay, let’s go to Belmont. So, they turned it on, and you
can, there’s cars passing, you could read the signs on the road and he
loved it. I did see a big change in his restlessness and his anger in those
two weeks.” (S-5)
“It was only for two weeks so 10 days, 5 days a week. … maybe if you
give them more time then they will get used to it. These residents take
time for them to stimulate something, just like a baby.” (S-2)

Duration of therapy

Flexibility in scheduling
VR therapy

“We kept the staff communicated and informed but sometimes the
residents were just not, it was not their day, they were having a bad
day… So, we didn’t offer the treatment, or we didn’t offer the treatment
every single day for some of the residents.” (R-3)

Staff dependency

“The other couple of scales that we had to do or collect information was
dependent on the staff… they did an observation of their agitation and it
was a scale that had to be monitored on, were they wandering, were they
agitated, and we found that scale often not completed.” (R-3)

Staff commitment

“Who’s going to make the time? It just can’t be half done; it would
have to be a commitment. You don’t want to have to get the machine
swept into a closet and bring it out once a year”. (R-3)

Therapy area

“we were trying to do the treatments in their bedrooms, but these rooms
are their home. So, they have family pictures up and other pictures up
which makes that environment very nice but doesn’t work well to run a
BroomX machine.” (R-1)
“With residents with dementia, approaching anybody to put anything
over your head can be quite frightening…. you can scare people and
then you can create a really negative reaction.” (R-3)

Technical issues

S=Staff informant, R=Researcher informant

3.5.1

Theme 1: A noticeable change in the pilot participants

All informants mentioned noticing at least one behavioural change in residents who
completed the VR therapy. The perception related to the idea of a change surfaced over
and over again during the interviews. I presented my interpretation of the informants’
subjective accounts centered around this change in the following sections.
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Sub-theme 1: Communication. The most prominent sub-theme within Theme 1 of
observed change was that the residents started to speak, to make gestures attracting
attention or to respond to verbal communication, and to show interest in initiating and
continuing a conversation. I spotted at least nine residents in common from the accounts
of family, staff, and researchers who were communicating better after receiving the VR
therapy. The following quote shows how striking this “change” was:
We had a resident who hadn’t been verbal in over a year. All of a sudden, started talking about the cows
and her family called me because when the family would come to visit, they said my mother hasn’t talked in
over a year and why is she talking about cows, where are these cows? I said, well you know you consented
your mother to be in our VR study and she has been having daily VR sessions with the farm scene and it
clicked with the family right away (Researcher-2)

A staff informant (S-4) was excited (my field notes indicated, “her eyes lit up with joy”)
describing a resident to me, we can communicate better with her. We will tell her I love
you and she gives us the biggest hugs and she will kiss us on the cheek. The staff
informant (S-4) had been caring for this particular resident for the last three years.
According to her, the resident usually looked at the windows or at the walls whenever she
was in the resident’s room making the staff member (S-4) feel as if she was invisible. The
staff informant (S-4) was surprised when the resident, after completing the VR therapy,
noticed her and showed her acts of affection (kisses and hugs). The informant (S-4) also
mentioned that the resident continued to show friendly gestures such as smiles/hugs at
least four months after the pilot ended.
Out of all perceptions related to “change”, I identified a representative example in the
reaction of a family member (F-2) while describing a conversation between her and her
father. The family member informant (F-2) was a busy person. She lived at the outskirts
of the city. When I contacted her over the phone to discuss her participation in this study,
she agreed right away. My understanding was that she was eager to share her
experiences. She came at 7:00 in the morning for this interview driving for approximately
an hour. According to her (F-2), the resident (her father) used to have difficulty finding
words during a conversation prior to the pilot. She and her father stared at the floor and
did not say much to each other on the many occasions during their regular visits. While
her father was participating in the pilot, to her surprise, her father participated in an actual
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verbal conversation with her. One could almost feel her enthusiasm though her physical
appearance (the field notes indicated, “her cheeks were red with excitement”):
Well periodically, like the last couple of times I’ve seen him, I’ve found him much better. Able to carry on
a conversation a little bit better, able to find words, he has had real problems with word finding and he was
able to find more words the last couple of times I was here (Family-2)

Sub-theme 2: Demeanor. Many informants mentioned a change in residents’ typical
demeanor during and after (more or less two months) the pilot. For instance, a staff
informant (S-6) said, I think she has changed, she is more calm and more understanding.
A family member (F-3) experienced an emotional turmoil when describing her mother.
She (F-3) asked me if family members in my culture send their mother/father to LTC
homes. My understanding was that she felt somewhat guilty for not being able to take
care of her mother at home. She (F-3) was upset, crying at times during the interview.
The family member (F-3) mentioned that her mother used to rub her own hands during a
conversation whenever she visited her, sensing that something was bothering her mother.
Family member (F-3) reported that when she was a little girl, she remembered that her
mother used to rub her own hands if there was a tension in the relationship between her
parents. The family member (F-3) stated that her father was an alcoholic. She used to
think that her mother was not happy being away from her. She stated that she felt that
rubbing hands was her mother’s way of showing being upset. She noticed that her mother
stopped rubbing her hands while she participated in the pilot. She reported, however, that
her mother started massaging her own hands again two months after the VR pilot ended.
The following quote from a staff informant (S-7) about a resident during and shortly after
(a month) the VR therapy shows the idea of a “change” in a resident’s demeanor:
She used to get kind of angry and not be compliant a lot. I found a big improvement with her…She was
being, she is more being, I’m trying to say the word, she wasn’t having as much behaviour. She was, I
mean even her table mates, she used to show kind of that behaviour with them… she was being more kind
to them, wanting to help them … she wanted to make sure that they had their dinner and she wanted to
make sure they got their dinner (Staff-7)
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Sub-theme 3: Being relaxed. Informants described a change in residents’ anxious
behaviours/uneasiness. Staff informants (S-2, S-6, S-7) noted to me that the residents
with moderate to severe dementia usually do not sit in one place for long. They either
wander or simply lose interest in any conversation/audio-visual experience. For example,
when I was waiting in a TV area near the nursing station to recruit a staff informant for
this study, I noticed that there were only four residents sitting in front of the TV. Two of
them were fast asleep and two of them were immobile. Those not sleeping were not
watching TV. One resident was looking out the window and another was looking at
people passing by. When informants mentioned residents being relaxed, being seated in a
chair, and actually watching VR images for 30 minutes, I took these remarks seriously. In
my interpretation, being relaxed is a noticeable change.
We didn’t expect that they would sit for 30 minutes through a VR session and a lot of residents
did. Not everyone but a lot of residents did and that was kind of surprising (Researcher-1)

Sub-theme 4: Attention. Informants mentioned residents being attentive to their
surrounding environment, to their activities of daily living, and to their conversations. An
account from one staff informant (S-7) was particularly emotional to me. She described a
resident she had been caring for the last four years. This resident was fixated on being a
young mother with a baby. The resident used to carry a baby doll with her wherever she
went and kept few stuffed toys on her bed. The staff informant (S-7) used to start
conversation with this resident inquiring of her baby (e.g., How is your baby today? What
is your baby doing now?). For almost a year prior to the start of the pilot study, staff
informant (S-7) noticed that the resident stopped paying attention to her baby doll. If she
asked about the baby, the resident would stare at her without any expression as if the
resident did not know what she was talking about. The staff informant (S-7) reported
noticing one day that the resident was paying attention to her baby again. The resident
was participating in the pilot study at that time. The staff informant (S-7) stated that she
was not sure if it was the VR therapy or something else but did note that a change in
attention and behavior did occur.

59

I walked into her room to tell her it was breakfast and she had her baby standing up looking out the
window and she never used to do that which is so good because she is actually interacting with those things
on her bed (Staff-7)

Sub-theme 5: Being active. I learned from several informants that residents were active
during VR therapy in terms of willingly dressing themselves, not resisting baths, and
taking care of their personal belongings. I present the following summary from a staff
informant’s (S-4) account of a resident’s change in ‘being active. Staff informant (S-4)
noted that a particular resident used to stay in her room most of the day, even during
mealtimes. LTC home staff members used to serve breakfast in her room. The resident
would get agitated if any staff persuaded her to come out of her room. There was an
unofficial consensus among the staff to leave this resident alone. After this resident
joined the VR pilot study, she began to come out of her room more often. To the surprise
of staff informant (S-4), the resident started to have her breakfast in the dining area
instead of in her own room.
Sub-theme 6: Eating behaviour. Informants described a single resident showing a
considerable change in her eating behaviour. Prior to being enrolled in and completing
the pilot VR study, the staff and researcher informants (S-6, R-2) observed the resident
being agitated/anxious for a considerable time of the day. She used to wander around the
facility, did not sit in the dining area long enough to finish her meal, and did not sit down
while eating in her own room. When the resident was in the pilot study, the informants
(S-3, S-4, S-6, R-1) noticed that she was calmer/more relaxed. She actually ate meals
while seated in the dining area. A staff informant (S-6) mentioned that the resident gained
weight during the course of the pilot VR study. However, the calm demeanor reverted to
restlessness after the pilot ended, according to two informants (S-6, R-2).
3.5.2

Theme 2: Implementation of VR in a LTC setting

I compiled the experiences related to conducting the therapy, lessons learned, and
suggestions for future implementation of VR therapy at a LTC home setting within this
theme. The sub-themes comprising the theme of implementation are presented in the
following sections.
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Sub-theme 1: Library items. In my judgement, a majority of the informants believed a
tailored VR library based on family members’ feedback was useful in drawing residents’
attention to the VR therapy. For example, residents having experience in farming
responded better with the library item, “Farm”, whereas, residents passionate about
driving repeatedly watched the library item, “Truck driving”.
Notably, library items revealed some aspects of residents’ memory/reaction to a memory
previously unknown/forgotten over time. For example, a family member (F-1) mentioned
that a staff asked her whether her mother had any traumatic memory related to the image
of an Alpine meadow. She could not think of anything that might frighten her mother
watching a peaceful image of a meadow. The family had immigrated to Canada from
England after World War II. She discussed this incident with her older sister living in
England. Her older sister remembered that her mother used to work as a nurse during
World War II near the Bavarian Alps. Her older sister also remembered that her mother
used to tell stories about people being killed in the meadows of Bavaria. She discovered a
possible reason for her mother’s reaction to a seemingly peaceful image of the library
item, “Bavaria”. I believe such experience is a lesson for those interested in
implementing VR therapy for older adults with dementia.
Sub-theme 2: Duration of VR therapy. I acknowledge a consensus among the
informants regarding a longer duration of VR therapy. The LTC home staff and
researchers were positioned to observe the effect of the duration of the VR therapy from
different perspectives. Staff members observed the therapy effect on BPSD in residents’
daily lives, long after the pilot ended while researchers measured the more immediate
impacts of VR therapy on BPSD. However, both groups of informants agreed on one
aspect; a two-week long duration of VR therapy is not sufficient to affect residents’
BPSD, let alone have a sustained effect.
Sub-theme 3: Flexibility in scheduling VR Therapy. I realized from my two months
observation of the environment and workplace culture at the study site and the interviews
that any intervention concerning older adults with dementia in LTC home setting needs
flexible scheduling. In my understanding, an individual with dementia may be
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overwhelmed cognitively, physically or sensorially on a particular day to complete a
visit. Therefore, someone interested in implementing similar intervention for people with
dementia must follow a flexible schedule.
We would set up the residents trying to find out from the staff which morning or afternoon would work
better.. we had to organize to see if morning was better for them, was afternoon better….if it wasn’t a good
time or a good day we would re approach them after lunch. (Researcher-3)

Sub-theme 4: Staff dependency. I sensed a tension between the staff members at the
study site and the researchers who ran the VR pilot study beginning the day I started
recruiting staff members. Staff informants (S-2, S-3) mentioned that they were not paid
enough to support a research study at the facility during the recruitment period of this
study. I worked as a PSW for six months during my first year as an immigrant in Canada.
I understand that the job of a PSW is stressful due to tight scheduling, among other
stressors.
The VR pilot study required staff members to complete BPSD measurement tools
because staff were positioned to observe the everyday lives of the residents enrolled in
the pilot. Informants’ accounts were that the added responsibility of completing
measurement tools on top of their regular care activities was overwhelming. A researcher
informant (R-3) mentioned staff dependency as a challenge in completing the BPSD
measurement tools.
Very busy, so it was hourly. They had to check and document their behaviour on a paper trail. Yes, it was a
challenge. And a couple of things, we didn’t know whether it was accurate because sometimes you put the
mark, or did they just put the mark in there and complete it (Researcher-3).

A staff informant (S-7) mentioned that the staff members considered the residents as their
family. My interpretation from staff informants’ accounts is that the staff are busy with
their workload but they go above and beyond to create an enjoyable environment for the
residents. According to an informant (S-7), if the staff are educated on the therapy, they
may act in a different way.
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They just knew that they were taking them to this little room, something was happening and then they
brought them out, they didn’t know anything else and there was an education piece but it was during work
hours and staff didn’t have the time to come (Staff-7)

Sub-theme 5: Staff commitment. I realized that staff involvement is vital in
implementing VR therapy in a LTC home setting during the interviews. Staff informants’
accounts (family=1, staff=7, and researchers=3) revealed that they were well-positioned
to motivate the residents to attend the therapy, to transfer residents to and from the
therapy area, and to set up, to maintain, and to operate the VR machine. A researcher
informant (R-3) explained how important staff commitment is for future implementation
of VR therapy;
Who’s going to have the time to do it? Who’s going to make the time? It just can’t be half done; it would
have to be a commitment. You don’t want to have to get the machine swept into a closet and bring it out
once a year (Researcher-3)

Sub-theme 6: Therapy area. All researcher informants mentioned the importance of a
dedicated area for VR therapy in order to optimize a successful implementation. The
researchers transported the VR machine (BroomX©) to residents’ rooms to avoid conflict
with their daily schedule at the beginning of the pilot. They soon realized the
impracticality of setting BroomX© in residents’ room for reasons such as (1) the VR
image projection was obstructed by wall decorations, (2) the VR sound was interrupted
by conversation among staff and residents in the hallway, (3) the VR experience was
shortened for machine set up time, and (4) the internet signal was interrupted inside the
living area of the residents. Further, the interrupted VR image and sound agitated the
residents. According to researcher informants (R-1, R-3), once a dedicated VR therapy
area was established, the residents’ agitation was reduced.
Sub-theme 7: Technical issues. Starting the VR pilot study inside a LTC was
problematic. During the interview, all three researcher informants mentioned several
technical issues such as the use of a headset, disinfecting protocol before and after using
the headset, interrupted internet (Wi-Fi) connection, and the VR app control. However,
they solved all of those issues when they started using a projector, a land line for internet,
and a dedicated space for therapy.
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3.5.3

Theme 3: Uniqueness of the VR therapy

One concept that surfaced repeatedly during the interviews was that the VR therapy is a
unique intervention. All fifteen informants mentioned that a tailored VR library was the
key for the therapy being so special. The following quote is an example of this
perspective:
It is very individual, someone might be back in their childhood, someone might be back in their married life
in their home, with their children, so that’s the piece for us is to figure out where people are and to connect
with them at that level with the VR and so if that’s where people are, they are fighting the current
environment, they fight today because they think they are living in 1940 or 1950 or wherever and so you
remove that with the VR, put them where they are comfortable. So, they are calm, they are relaxed
(Researcher-2)

A family informant (F-3) said, with dementia you know that a person lives in a different
time-line. So that also helps when they feel that they are in their own zone. My
interpretation is that the VR therapy offered a channel to escape from confusing reality
into a world meaningful to the residents. The residents might have felt comfortable being
in a familiar environment that reflected on their demeanor, their daily activities, and their
emotional state.
There was a consensus among the informants suggesting that the study site should offer
VR therapy to all their residents on regular basis. The following excerpt supports this
idea.
I think it is a break on the nursing homes because they spend all their time here. So, it was good for them to
realize, I mean to continue the life that they are living right because even if they’re here, they are still
thinking about what happened in their life and remember. So, I think it is such a very good idea this
program because it helps them recognize and connect with things that sometimes is on their minds and it
helps them (Staff-6)

3.5.4

Theme 4: Duration of VR effect

Informants’ accounts revealed that the change in residents’ behaviours with VR therapy
did not last long. Even though the informants mentioned that they noticed a change in
residents for a week to months after pilot ended, they were not sure if that change was
related to VR therapy. I suspect the interview prompts related to the duration of VR effect
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might have motivated them to say the “change” lasted for a while. For example, when an
informant mentioned a change in a pilot participant’s behaviour, I prompted, “how long
the change was noticeable?” The informant’s response might be based on his/her sincere
memory or an assumption.

3.6

Discussion

My position is simply to describe my interpretation of various subjective accounts on the
same phenomenon (VR therapy). I recognize that informants positioned in various levels
(some directly caring for the residents, some met residents only during the pilot study,
and some are familiar with the residents long before living in a LTC) interpret their
perception based on their own mindset, their own professional stance, and their own
cultural/spiritual beliefs. However, I recognize a probable reality amidst existing multiple
realities that the therapy brought some kind of “change” in residents’ behaviour, their
participation in daily activities, their mood, and their attention. I am not in the position to
judge whether those “changes” were beneficial or detrimental for the residents.
The following section attempts to compare my interpretation with different studies
having similar construct to aid the reader to conceptualize how my findings are similar to
or different from others. Similar to my interpretation, studies noted that individuals with
dementia were engaged to VR technology (Baker et al., 2020; Ferguson et al., 2020;
Martinez-Pernia et al., 2017; Rose et al., 2019), were more relaxed during virtual
experience (Appel et al., 2020), were aware of their surrounding environment (Moyle et
al., 2018), and were attentive to their daily activities (McEwen et al., 2014). Studies also
echoed the informants’ perception related to the use of headset being uncomfortable
(Baker et al., 2020; Ferguson et al., 2020; McEwen et al., 2014); VR machine set-up
being time consuming (Moyle et al., 2018); and VR experience in a space with clutters,
background noise, and bright light being challenging to keep the participants engaged
(Moyle et al., 2018). Unlike this inquiry, they reported that the participants’ excitement
declined after the first session as they lost interest over time watching the same image
(Moyle et al., 2018; Rose et al., 2019), picture quality being not satisfactory (Appel et al.,
2020), and lack of an accompanying audio file (Appel et al., 2020).
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3.6.1

Limitations

Achieving reflexivity was a challenge for me because I am trained to explore reality with
positivist lens. I adapted techniques such as referring back to my fieldnotes, involving
two investigators in evaluating audio recorded interviews and transcript data to overcome
this challenge. I realize that a video recorded interview instead of an audio recorded
interview might have produced rich data in terms of capturing emotional aspects of
informants’ accounts. I declare thematic analysis based on audio recorded interview data
and field notes (possible introduction of my preconceptions) as a limitation of this work.

3.7

Conclusion

Overall, informants in this qualitative inquiry reported that a “change” in the residents
was noticeable during the VR therapy. Given the infancy of the research area, this
interpretive description may ignite interest in someone involved in caring a person with
moderate to severe dementia. Although my findings applied to this particular study
setting, the thick description related to VR therapy, its implementation, and its effect on
older adults with dementia represent an important first step in studying the effects of VR
therapies in older adults with dementia. More research into the perceptions of people with
dementia and their caregivers is needed to build a more complete picture of the potential
benefits of this type of therapy.
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Chapter 4
4

Effectiveness of virtual reality therapy: A protocol for CRT

This chapter presents a protocol for a cluster randomized control trial (CRT) informed by
our findings from the pilot study (Chapter 2) and the narrative inquiry (Chapter 3)
formatted as a Canadian Institutes of Health Research (CIHR, 2020) project grant
application (https://cihr-irsc.gc.ca/e/39187.html ).

Chapter summary
BACKGROUND: Around 90% of long-term care (LTC) home resident Canadians with
dementia exhibit at least one behavioural and psychological symptoms of dementia
(BPSD). The cost of dementia care was CAD 8.3 billion in 2011 and is expected to
increase to CAD 16 billion in 2031. In clinical practice, non-pharmacological approaches
are considered as a first-line strategy for dementia care. We conducted a pilot feasibility
study in an Ontario LTC home with a Cognitive Stimulation Therapy (CST) (VR
therapy) and learned that virtual reality (VR) therapy was feasible, safe (no adverse
events) and had a small to moderate effect on BPSD. We also conducted a post-pilot
qualitative inquiry and learned that residents’ behaviours were perceived to change for
the better by their caregivers and pilot researchers. Therefore, we want to explore if usual
care plus VR therapy reduce BPSD in older adults with dementia living in Ontario LTC
homes compared to usual care alone. We also want to compare the cost between the
intervention (usual care plus VR therapy) and control (usual care). METHOD: The
proposed study will be a matched pair CRT. Participants are LTC residents with
dementia. We will provide VR therapy with BroomX©
(http://www.broomx.com/broomxvr.php) for 30 minutes, five days a week for two
months. The primary outcome is a collection of instruments measuring BPSD.
RESULTS: Effect of VR therapy on BPSD. CONCLUSION: If our study shows that VR
therapy is effective at reducing BPSD, relevant stakeholders can implement the
intervention.
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4.1
4.1.1

The need for a trial
What is the problem to be addressed?

The Population Health Expert Panel [PHEP] (2016) estimated that 513,953 Canadians
aged 65 years and older were living with dementia in 2013–2014. They also predicted
that the number of Canadians living with dementia would almost double by 2033 due to
the growing number of older adults (PHEP, 2016). Dementia prevalence is highest in
Ontario (7.3%) compared to the national average (6.8%) (CIHI, 2014a).
The cost of dementia care (Canadian health care system cost and caregiver out-of-pocket
cost) was CAD 8.3 billion in 2011 and expected to increase to CAD 16 billion in 2031
(PHEP, 2016). The majority (71%) of Canadians with dementia live in LTC homes
(PHEP, 2016). In Canada, LTC homes and family caregivers are the largest contributors
to direct costs associated with dementia care (e.g., caregiver time; emergency department
[ED] visits due to falls, injuries, and cardio-vascular diseases [CVD]; transportation; and
pharmacological interventions) (PHEP, 2016). Canadian LTC homes, where many older
adults with dementia live, spend CAD 6.5 billion in staff salary a year (CIHI, 2014b).
The average cost of one ED visit is CAD 148 (Dawson & Zinck, 2009). The total cost of
ED visits was CAD 8.8 million in 2012 (CIHI, 2014c). The cost of psychotropic drugs for
people with dementia was CAD 200 million in 2011 (Manuel et al., 2016).
Dementia is a syndrome that include a group of progressive conditions in which cognitive
function is affected primarily (APA, 2013). Dementia predominantly affects older adults
(NICE, 2013). Among the LTC residents with dementia, 50.4% were diagnosed with
moderate dementia and 86.1% with severe dementia (PHEP, 2016). A survey among 301
LTC residents (mean age=83.5 years) revealed that 87.3% exhibited at least one BPSD,
also referred to as responsive behaviours (Stewart et al., 2014). BPSD include apathy,
depression, sleep disorders, agitation, aggression, and psychosis (Linde et al., 2014).
BPSD can worsen the prognosis of dementia (Stern et al., 1987) and can intensify
caregiver distress (Allegri et al., 2006). Since BPSD are prominent among persons with
dementia and burdensome to the staff in LTC and to their family caregivers, the
following research questions were posed for the current study.
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4.1.2

What are the principal research questions to be addressed?

Primary research question. Does usual care plus VR therapy reduce BPSD in older
adults with dementia living in Ontario LTC compared to usual care alone?
Secondary research question. What is the cost comparison between the intervention
(usual care plus VR therapy) and control (usual care) group in terms of the use of
psychotropic medications, one-to-one staff service, and emergency department (ED) visit
in LTC perspective?
4.1.3

Why is a trial needed now?

The American Geriatrics Society (2012) strongly cautions against using pharmacotherapy
for BPSD management because of the increased risk for cognitive decline, falls, and
serious CVD adverse effects leading to increased mortality. The RNAO best practice
guideline on dementia based on current evidence (2016) recommended nonpharmacological approaches as a first-line strategy for dementia management instead of
pharmacotherapy. Non-pharmacological interventions such as cognitive behavioural
therapy (Stanley et al., 2013) and CST (Morley & Cruz-Oliver, 2014) are considered the
first line of therapy for BPSD management (Kales et al., 2015). CST is a cost saving
approach (approximately CAD 1200 per person) in terms of health and social care cost
(Livingston et al., 2014).
CST, such as music therapy, reduces agitation (n=397, standardized mean difference
[SMD]=−0.49; 95% CI, −0.82 to −0.17), anxiety (n=258, SMD= −0.64; 95% CI, −1.05 to
−0.24) and depression (n=250, SMD= −0.32, 95% CI, −0.68 to −0.04) (Abraha et al.,
2017). CST-based aromatherapy reduces agitation (n=71, SMD=11.1, 95% CI, 19.9 to2.2) and behavioural symptoms (n=71, SMD=15.8, 95% CI, -24.4 to-7.2) (Forrester,
Maayan, Orrell, Spector, Buchan, & Soares-Weiser, 2014). CST using multiple sensory
stimulation (Snoezelen) revealed a trend in reducing BPSD (n=117, SMD=-1.22, 95% CI,
-4.08 to 1.64) (Chung, Lai, Chung, & French, 2002). However, the evidence on the
effectiveness of CST in reducing BPSD is inadequate (Lancioni, Cuvo, & O’Reilly,
2002; Livingston et al., 2014).
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VR therapy is a CST-based approach which generates an immersive environment that
imitates a physical reality (Shuchat, Ouellet, Moffat, & Belleville, 2011). People with
dementia can enjoy and prefer the virtual experiences (D’Cunha et al., 2019) but its effect
can be negligible on emotion (ES=0.1) and execution of daily activities (ES=0.1) when
provided with a headset without music (Kim, Pang, & J. Kim, 2019).
We conducted a VR pilot in an Ontario LTC home from November 2018-January 2019
using a projection device (MK player 3600) and BroomX© technology, introduced in
2017 (The Projected VR Company, 2019). Unlike other types of VR technology, users of
BroomX© do not need to use a headset, can control the distance of images (bringing the
image closer for better look), and can incorporate customized music with customized
images (The Projected VR Company, 2019). Our pilot study (please refer to Chapter 2)
showed that VR therapy was feasible, safe (no AE) and had a small to moderate effect on
BPSD among persons with dementia (n=24, ES=0.4 for CSDD, ES=0.2 for CMAI, and
ES=0.6 for proportion of night-time sleep). Further, post-pilot qualitative inquiry (please
refer to Chapter 3) revealed that the participants with dementia were perceived to be
relatively calmer, more active, eating and communicating better than usual during the
therapy.
Unlike pharmacologic interventions, non-pharmacologic interventions are not required by
provincial or federal regulations to demonstrate their effectiveness before clinical
implementation (Office of the Auditor General of Canada, 2011) and thus researchers
have little motivation to support clinical trials into their efficacy or effectiveness.
However, premature dissemination of non-pharmacologic interventions exposes
vulnerable older adults with dementia to the potential risks of ineffective therapies and
exposes a health care system limited by constrained resources to potentially wasteful
expenditures. These considerations highlight the importance of a carefully designed
study.
4.1.4

How will the results of this trial be used?

If the proposed study shows that VR therapy is effective at reducing BPSD, then results
can be shared with relevant stakeholders for practice, planning, policy making, and
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creating awareness through interactive engagement. The deliverables would be: 1) a
learning module on how to conduct VR sessions at a LTC facility, cost of VR therapy,
and what to expect as behavioural outcomes from the participants (a short video and a
manual including a case-study exercise) for LTC staff and LTC policy makers; 2)
interactive education and training sessions (group discussions, presentation, poster) for
LTC staff and LTC policy makers, family caregivers, and health professionals; 3)
ongoing online survey for decision support, provision of recommendation, and workflow
integration for LTC staff, family caregivers, and health professionals; 4) a practice
guideline for timely knowledge translation for LTC staff, family caregivers, health
professionals, and health educators; 5) an online forum for interactive and progressive
problem solving for LTC staff and family caregivers; and 6) peer reviewed journal
publications for evidence-based decision making aiming for better quality of care for
researchers.
4.1.5

Are there any risks to the safety of participants involved in the trial?

There are no known risks to the safety of participants from BroomX© VR therapy.
Although we did not observe cybersickness in the pilot (please refer to Chapter 2),
cybersickness or visually induced motion sickness and interference with hearing
aids/eyeglasses are concerns when VR is experienced using a headset (Kim, Rosenthal,
Zielinski, & Brady, 2012). A recent study using a headset (n=66, mean age=80.5±10.5,
diagnosed with cognitive impairment) showed no cybersickness in contrast with previous
published concerns (Appel et al., 2020).
For added safety, we will appoint a RA to accompany the participant to and from the
intervention area, to sit beside him/her during the intervention sessions, to monitor
him/her for any negative behaviour or change of mind regarding
continuing/stopping/changing images during the session, and to stop the session if needed
to minimize any unforeseen risk.
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4.2
4.2.1

The proposed trial
What is the proposed trial design?

The proposed study will be a matched pair CRT with a Zelen approach (Zelen, 1974) to
consent that will compare usual care and VR to usual care and attention in Ontario LTC
resident older adults with dementia.
4.2.2

What is the planned trial intervention?

VR Therapy. We will provide the intervention with BroomX©
(http://www.broomx.com/broomxvr.php) software and MK Player 360© (Broomx
Technologies, 2019) within the participating LTC homes. The intervention area will be
clutter free and devoid of windows/windows with blinds to avoid visual distractions. We
will use the Cross Water Digital Media (https://crosswater.net/) created library items, set
to music (72 beats/minute) already developed for our pilot. We will customize the library
items based on participants’ preferences informed by their SDM/caregivers. There will be
no limit to the frequency or variety of the played library items. The maximum duration
and frequency of each session will be 30 minutes, five days a week for two months.
We will set-up the MK Player 360© and will project the VR images before the
participant enters the intervention area for efficient time management. We will customize
the timing of the intervention for each participant to avoid their usual lunch time, visiting
hours, and nap time and to optimize their medication regimen . If a participant misses a
session for any reason, we will allow him/her a makeup session within 48 hours. We will
not limit the number of missed sessions. We will track the number of missed sessions and
the reason(s) for missing.
Usual Care. The usual care for all participants includes 24-hour nursing and personal
care; access to a physician, other health professionals, and social worker; access to foot
care, laundry and housekeeping, meals, recreation, and social programs; and assistance
with medication and activities of daily living along with any other typical
daily/weekly/monthly sessions held in each facility (e.g., attending spiritual/religious
services). Because the VR group will receive an additional 30 minutes of attention where
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occasionally the RA would hold the participant’s hand, we attempt to mimic the amount
of attention in the control group to reduce any performance bias.
4.2.3

What are the proposed practical arrangements for allocating
participants to trial groups?

The unit of randomization will be LTC homes (cluster) and the unit of intervention will
be individuals. We will use a set of eligibility criteria to recruit individuals and LTC
homes (i.e., a matched pair) to balance the prognostic factors. We will randomize each
matched pair either to the intervention or to the control group. Although residents will be
informed and asked to consent to participation in research, they will not be informed that
they are part of a randomized trial.
4.2.4

What are the proposed methods for protecting against sources of
bias?

Selection bias. We anticipate that residents (their families) may apply for homes offering
their preferred care if they were aware of the clinical control trial groups, thus
introducing a selection bias. We will proceed with Zelen method of consent (Zelen, 1974)
(residents would be unaware that their home is part of a randomized trial). Instead, they
would be informed of the study procedures and asked to consent to follow-up to
minimize such bias.
Performance bias. The control group will be unaware of their participation following
Zelen’s (1974) work and thus performance bias will be controlled. Psychotropic drugs are
frequently used in LTC homes to treat BPSD (Kuronen, Kautiainen, Karppi, Hartikainen,
& Koponen, 2016; Preuss, Wong, & Koller, 2016). Moreover, LTC homes are mandated
in Ontario to offer a variety of recreational activities such as watching movies, listening
to music, board games, group walking, and gardening (Long-Term Care Homes Act,
2007). Therefore, we will identify and record psychotropic drug usage and other
recreational activities as possible co-intervention(s). We will perform a statistical
adjustment for imbalances introduced by these co-interventions and thus control
performance bias. We will use intention-to-treat analysis to compare the groups in terms
of the intervention to which they were randomly allocated, regardless of protocol
deviations and participant compliance or withdrawal (Schwartz & Lellouch, 1967) to
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minimize performance bias. Intention-to-treat analysis includes all participants
randomized into a trial regardless of what happened subsequently (e.g. drop-out, lost to
follow-up, incomplete data, crossover) (Newell 1992).
Attrition bias. Risk of attrition bias arises either from (1) residents dying (agestandardized all-cause mortality rates among Canadians aged 65 years and over with
dementia in 2013-2014 was 10.7%; 95%CI, 8.9%-12.8% [CIHI, 2017]), (2) being moved
from that LTC home to another home or to palliative care (5%; 95% CI, 1.6%-11.3%
[CIHI, 2018a]), or (3) being hospitalized for extended periods of time (ED visit and
hospitalization rate for Ontarians in 2015-2016 was 29%; 95% CI, 20.4%-38.9% [CIHI,
2018b]). Attrition bias is not expected to be related to the intervention and, therefore,
should be similar between groups.
Detection bias. To minimize detection bias, we will use routinely collected data to
evaluate the outcome and will measure the same outcomes at same interval for both
groups. In addition, the data analyst will be blinded to group allocation.
4.2.5

What are the planned eligibility criteria?

The eligibility criteria for LTC homes (cluster), are: 1) report care using RAI-MDS 2.0,
2) support people with dementia, 3) a minimum of 60-beds for people with dementia, 4)
have available clutter-free space (e.g., Snoezelen room) for the VR machine set up, and
5) can ensure on-call staff during VR sessions.
The eligibility criteria for participants (unit of intervention) are: 1) resident of a
participating LTC home, 2) age ≥ 18 years, 3) diagnosed with dementia, 4) able to be
transferred to the intervention area, and 5) have a SDM who can provide consent.
Residents will be excluded on the basis of 1) documented severe vision problems (e.g.,
macular degeneration, glaucoma, etc.), 2) documented severe to profound hearing
impairment, 3) a SDM who is involved in this trial or is a staff or administrative member
of the participating LTC home, 4) residents at the end of life, and 5) residents with
epilepsy. Severity of vision and hearing impairment can be operationalized if needed
during the trial.
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4.2.6

What is the proposed duration of treatment period?

We propose a two-month period intervention based on our findings from the post-pilot
qualitative inquiry (please refer to Chapter 3) and relevant literature (Geraets. et al., 2019;
Ho et al., 2019; Park et al., 2020). The time period offers sufficient exposure to the VR to
elicit observable and measurable changes in the behaviours of the participants.
4.2.7

What is the proposed frequency and duration of follow up?

We will measure the outcomes at onset (i.e., baseline, month 0) , 2 months (immediate
post-intervention), and 6 months (4 months post-intervention follow-up). The 4-month
post-intervention follow-up permits evaluations of any sustained VR effect on BPSD.
Due to the deteriorating nature of the condition over time (depending on types of
dementia) (Perera, Javeed, Lyketsos, & Leroi, 2017), we would not expect a 6- to 12month long-term effect without either continuing or re-initiating the intervention.
4.2.8

What are the proposed primary and secondary outcome measures?

The primary outcome is a collection of instruments all measuring BPSD. Specifically, we
will include instruments used for RAI-MDS 2.0 as LTC homes are mandated by Ministry
of Health and Long-Term Care (MOHLTC, 2013)
(http://health.gov.on.ca/en/public/programs/ltc/docs/RAI-MDS.pdf ) to collect them. LTC
also regularly collect data on dosing of psychotropic drugs (prescription, dose, and
change of dose), one-to-one staff service (duration and frequency), number of ED visits,
and proportion of sleep (Hutchinson et al., 2010), all of which are clinically meaningful
and relevant to BPSD.
RAI-MDS 2.0 includes instruments such as DRS for depression and ABS for agitation
(Hutchinson et al., 2010). The DRS is a reliable (α=0.69) and a valid (correlation with
CSDD [r=0.69, p<0.01] and Hamilton Depression Rating Scale [r=0.70, p<0.0] is strong)
instrument to measure depression in LTC residents (Burrows et al., 2000). The ABS is a
reliable (α=0.8) and a valid (correlation with CMAI is strong, r=0.72, P<0.01) tool to
measure agitation in LTC residents (Perlman & Hirdes, 2008).
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We used instruments such as CSDD to measure depression and CMAI to measure
agitation in our pilot study (please refer to Chapter 2). We will use CSDD and CMAI
along with RAI-MDS 2.0 instruments to measure BPSD. The CSDD is applicable for
those with advanced dementia and is a reliable (α=0.84) and a valid (correlation with
Research Diagnostic Criteria Depression scale is strong, r=0.83, p < 0.001) scale for
depression (Alexopoulos et al.,1988). The CMAI is applicable for LTC residents (Linde
et al., 2014) to measure agitation (test-retest reliability coefficient=0.830; p<0.001 [Koss
et al., 1997]; and has a strong association with Agitated Behaviour in Dementia scale,
r=0.62; p<0.001 [Logsdon et al., 1999]).
Cost outcomes. We will measure the startup cost (VR machine, Wi-Fi connection,
storage and maintenance of VR machine, salaries of Research Coordinator [RC] and RA)
and direct cost of care (prescribed psychotropic drugs, one-to-one staff service, and
number of ED visits) within the LTC homes in monetary units using existing market
price. A simple cost comparison between the groups will aid future planning for VR
therapy at LTC home (health sector) level following Drummond and colleagues’ (2005)
work.
Safety Outcomes. We will report serious, unexpected, and related AE as safety
outcomes. AE refers to any unwanted event associated with the use of an intervention
(U.S. Food and Drug Administration [FDA], 2016). An AE is considered "serious" in
case of death, lethal event, inpatient hospitalization or prolongation of existing
hospitalization, a persistent or significant incapacity, congenital anomaly/birth defect
(FDA, 2016). The expected AE includes falls, nausea, dizziness, being panicked, and
being claustrophobic (D’Cunha et al., 2019; Ferguson et al., 2020; Park et al., 2020;
White & Moussavi, 2016). We will consider the AE related to the intervention if it affects
the participant during and right after the VR session. We will follow the AE until it is
resolved, or the study is completed. We will notify participants’ AE/severe depression to
LTC staff caregivers immediately for their knowledge and action.
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4.2.9

How will the outcome measures be measured at follow-up?

LTC homes are required to maintain accurate medical charts to record several of our
secondary and cost outcomes including falls; number of ED visits/accidents; psychotropic
drug use (Hutchinson et al., 2010). In addition, the Long-Term Care Homes Act (2007)
mandates that LTC homes routinely collect an accurate account of one-to-one staff
service and proportion of the total expected asleep time (8 hours, from 10:00 pm to 6:00
am). Thus, the RA will extract this data from the chart and enter it into the electronic data
collection system.
A member of the LTC staff who is most familiar with the resident will serve as a proxy
and complete the CSDD and CMAI at baseline and follow-up. Every effort will be made
to keep the same staff member as the proxy for an individual although different staff
members may serve as the proxy for different individuals. One of the members of the
research team (KC) will train the staff members to complete CSDD (intra-class
coefficients=0.84; Korner et al., 2006) and CMAI scale (intra-class coefficients=0.41;
Finkel, Lyons, & Anderson, 1992). RA will collect and enter questionnaire data into the
EDC.
4.2.10

What is the proposed sample size and what is the justification for the
assumptions underlying the power calculations?

Our pilot study (please refer to Chapter 2) showed that VR therapy caused a change in
CSDD score, ES= 0.4 (95% CI 2.4 to -1.7). We will only include LTC homes with at
least 60 beds for people with dementia. Given that our pilot study showed a 40%
recruitment rate, the cluster size (m) is approximately 24 residents. Considering a noncluster equality trial with a continuous variable (CSDD), the sample size (S) is 216
residents (108 per group) (Kohn, Jarrett, & Senyak, 2019) if the Type I error rate (α) is
5%, and power (1-β) is 80%. In absence of available literature on intra-cluster correlation
coefficient (ICC) for the CSDD, we used an ICC of 0.05 (Underwood et al., 2013) to
evaluate the design effect (D) (D=1 + (m–1) × ICC) (Donner, Birkett, & Buck, 1981).
Therefore, the total number of participants will be 464 (N total=k × m; k=number of
clusters; k=(S×D)/m [Donner et al., 1981]). The attrition rate of the pilot was 0%
(95%CI, 0% to-12.5%). However, the attrition rate with similar groups of participants
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(Canadian LTC residents with dementia) using a similar intervention for BPSD
management (Snoezelen) was 21% (95% CI, 7% to 42%) (Klages, Zecevic, Orange, &
Hobson, 2011). We have inflated the sample size by 42% given the upper boundary of
the 95%CI for attrition rate from Klages and colleagues (2011). Therefore, the sample
size for this trial is 659 participants or 28 LTC homes or 14 matched pairs.
4.2.11

Are health service research issues to be addressed?

We will conduct a cost comparison for this trial. Please refer to Section 2.8 for a
description of the cost variables being collected and Section 2.16 for a description of the
analysis.
4.2.12

What is the planned recruitment rate? How will the recruitment be
organized? Over what time period will recruitment take place? What
evidence is there that the planned recruitment rate is achievable?

Our pilot recruitment rate was 40% over six weeks. We modified pilot eligibility criteria
(i.e., less stringent) and will set the recruitment period for six months to achieve a 40%
minimum threshold. We identified 158 LTC homes across Ontario that are eligible for
participation (Appendix E: Eligible homes). From these homes, we categorized homes
according to 1) geographic area (urban/rural), 2) size (<100-bed/>100-bed), 3) ownership
(for profit/non-profit), 4) presence/absence of locked unit, 5) accreditation status, and 6)
served population (>50% indigenous/non-indigenous community). We will randomly
select two homes from each of the six categories until we have two homes for each
category (Figure 4: Flow diagram of recruitment, allocation, and analysis). We have
secured an agreement with 17 homes and the primary contact at each site is listed as a coinvestigator1. The homes have agreed to identify and contact the SDM of eligible
participants.1
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Figure 4: Flow diagram of recruitment, allocation, and analysis. Reprinted from
“CONSORT: Transparent reporting of trials: Cluster trials” by M. K. Campbell, G.
Piaggio, D. R. Elbourne, and D. G. D. Altman, 2012, British Medical Journal,
345(e5661) 6(7), Copyright 2012 by Campbell et al. Reprinted with permission.
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4.2.13

Are there likely to be any problems with compliance? On what
evidence are the compliance figures based?

The pilot study had an adherence rate of 21% mostly due to the rigid two-week
intervention period (no makeup session offered at another day, conflict in participants’
family outing schedule), technical difficulties in setting up the VR machine, and
preparing the intervention areas. We expect a high (30%) adherence rate to our proposed
intervention because 1) the intervention period has built in flexibility (we will offer
makeup session at another day if a participant miss the session for any reason, we will
coordinate with staff regarding participants’ family outing schedule), 2) we have
overcome the challenges in setting up the VR machine from our pilot experience, 3) and
have decided to use a single intervention area instead of participants’ own rooms for this
CRT.
4.2.14

What is the likely rate of loss to follow up? On what evidence is the
loss to follow-up rate based?

Please refer to section 4.2.4.
4.2.15

How many centres will be involved?
Please refer to sections 4.2.10 and 4.2.12.

4.2.16

What is the proposed type of analyses?

Primary outcome. The analysis of CRT needs to account for the clustered nature of the
data usually through consideration of the ICC (Donner, 1998). We will analyze data at
the participant unit level accounting for the ICC (Campbell, Mollison, Steen, Grimshaw,
& Eccles, 2000). For an example, we will report the mean differences of primary
outcomes between the groups in each matched pair (two–sample t–statistic), divided by
the square root of D (Murray, 1998; Campbell & Walters, 2014). D=1 + (m–1) × ICC
(Donner et al., 1981), where m is 24 (section 2.10) and ICC is 0.05 (Underwood et al.,
2013). We will perform multiple linear regression analysis convenient for interpretation
and reporting of cluster RCT with robust standard errors (V( 1- 2)=s21/n1+s22/n2;
V=variance of the difference,

1

and

2=mean

of group 1 and 2, s21 and s22=standard

deviation of group 1 and 2, n1 and n2 =size of group 1 and 2) in each matched pair to
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measure the effect of independent variables (intervention allocation, type of dementia,
age, sex [biological connotation depending on sex chromosome], psychotropic drug use,
and proportion of night-time sleep, LTC homes’ location, accreditation status, presence
of a locked unit, population served, and offered other recreational activities) on the
dependent variables (response in BPSD measuring questionnaires) with confidence
intervals (Campbell & Walters, 2014).
We recognize that clustered randomization does not necessarily balance covariates or
effect modifiers at the individual level (Wright, Ivers, Eldridge, Taljaard, & Bremner,
2015). Adjusting for covariates improve the power of a CRT by reducing the magnitude
of the inter cluster variation (Campbell, 2000). Since BPSD changes over time and since
we assume the clusters (LTC) are not homogenous, we will adjust the covariates for the
dependent variable using ANCOVA (Analysis of Covariance) in each matched pair at the
baseline. The possible covariates are participants’ type of dementia, age, sex,
psychotropic drug use, and proportion of night-time sleep; LTC homes’ location,
accreditation status, presence of a locked unit, population served, and offered other
recreational activities.
Cost analysis: We will report each cost item (inputs) related to VR therapy and will
compare the cost of care in each matched pair across the six categories. We understand
that the hourly rate of staff wage and cost of ED visits may differ among the clusters,
thus, we will standardize the rate of staff wage to be CAD 14 per hour (Government of
Ontario, 2020; https://www.ontario.ca/document/your-guide-employment-standards-act0/minimum-wage) and cost of one ED visit to be CAD 148 (Dawson & Zinck, 2009). We
acknowledge that cost comparison does not consider effect of VR therapy.
Missing data. We will report data missing completely at random, missing at random, and
missing not at random (MNAR) (Little & Rubin, 2002) in each matched pair at baseline,
at the end of study, and at follow up for transparency following the work of Huntington
and Dueck (2005). We acknowledge that no imputation method is appropriate for MNAR
(Chakraborty & Gu, 2009). However, we will perform multiple imputation (Rubin, 1987)
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within clusters (Campbell & Walters, 2014) to obtain statistically valid inferences from
missing data (van Buuren, 2018).
4.2.17

What is the proposed frequency of analyses?

A formal analysis will take place once upon study close out.
4.2.18

Are there any planned subgroup analyses?

There are no planned subgroup analyses.
4.2.19 Has any pilot study been carried out using this design?
We completed a feasibility pilot study on the use of VR therapy discussed in detail in
Section 1.3 and Chapter 2.

4.3
4.3.1

Trial management
What are the arrangements for day to day management of the trial?

Each site will recruit and follow their participants. We will use web-based data
management software hosted by EmPower Health Research
(www.secure.empowerhealthresearch.ca) as they managed the pilot and are familiar with
our protocols. EmPower will be responsible for monitoring the quality of the data,
generating missing data reports and creating queries to clarify nonsensical data. The
software offered by EmPower has demonstrated compliance with privacy and security
standards. RC will follow up with RA at each site to ensure queries are resolved on time.
RA will be able to generate a Participant Tracking Report to view a scheduled visit and
status of the visit (complete or incomplete).
4.3.2

What will be the role of each principal applicant and co-applicant
proposed?

The PI (MS) is a physician and doctoral candidate in Health and Rehabilitation Sciences
at Western University. She completed her medical education and training at Dhaka
University, Bangladesh and her Master’s in Public Health at Sydney University,
Australia. She is experienced in conducting RCTs both in community setting and clinical
research setting. She was responsible primarily for analysis of the pilot project data
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including preparing manuscripts for publication. She also conducted a qualitative inquiry
on the pilot including interviewing informants, analyzing transcript data, and writing
manuscript. The PI (MS) will oversee the majority of the day-to-day running of this trial
including addressing data management issues with RC, raising important issues with coinvestigators and organizing data safety and monitoring committee (DSMC) meetings.
She designed the RCT, including editing the application.
The Co-PI, Dr. Dianne Bryant completed her doctoral work in Health Research
Methodology, at McMaster University and has expertise in RCT design and quality of
life measurement. She was primarily responsible for submissions related to the pilot
project, including writing and editing of the application. Dr. Bryant’s research team will
serve as the methods center for this trial. Dr. Bryant contributed to the design of the RCT,
including editing the application. Dr. Bryant has received funding from national and
international agencies, including the CIHR and the National Institutes of Health.
The co-investigator, Dr. Karen Campbell is an advanced practice nurse in wound and
continence care leading the International Skin Tear Advisory Panel and serves as an
Associate Scientist at the Lawson Health Research Institute. She is an adjunct faculty
member at Western University having a strong interest in skin health. She was the
principal investigator of the pilot project and took the lead conducting the trial including
collecting the data, addressing data management issues, and raising important issues with
co-investigators. Dr. Campbell will train the evaluators and will continue to provide the
necessary expertise for the successful completion of the RCT.
The co-investigator, Dr. X is an Assistant/Associate Professor at Western University and
a health economist. He/She will oversee the design and conduct of the cost analysis
component of the trial.
The co-investigator, Dr. Y is an Assistant/Associate Professor at Western University and
a biostatistician specializing in design and analysis of RCTs. He/She will supervise the
statistical analysis.
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Coinvestigators (1-28) are site leads at the participating LTC homes. The site lead will
conduct in-service meetings with staff to make them aware of the study, facilitate any
training, and ensure the readiness of the VR therapy room if applicable.
4.3.3

Describe the trial steering committee and if relevant the data safety
and monitoring committee.

The members of the Steering Committee include Drs, Sultana, Bryant, Campbell,
Biostatistician, and LTC Administrators. A monthly report, prepared by RC detailing the
overall and individual center accrual rate, loss to follow-up, withdrawals, and compliance
with standardized protocols will aid in the resolution of pertinent issues.
Our DSMC consists of Mr./Ms. X, a biostatistician, Mr./Ms. Y, an epidemiologist; and
Drs A and B, who are both gerontologists with expertise in dementia care and a registered
nurse trained in geriatric medicine/dementia care. The DSMC will provide valuable
insight into the direction of this trial. For each meeting, the DSMC will be provided with
reports detailing recruitment, retention, and adverse events. The DSMC will not have
executive power but can provide recommendations and information to the Steering
Committee.
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Footnote
1

The statements were added because we would need to have these letters in place

and agreements in place before applying for funding in order to increase our chances of
being successful. However, I have not completed these tasks at this time for the thesis.
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Chapter 5
5

Discussion on designing the CRT

The following sections contain a discussion pertaining to a proposed future research
study designed to determine the effectiveness of virtual reality (VR) therapy for residents
with dementia living in long-term care (LTC) homes. The discussion will address the
design, ethical issues, estimation of sample size, analysis scheme, and directions for a
proposed cluster randomized control trial (CRT) (please refer to Chapter 4 of this thesis).

5.1

Why CRT design?

The CRT is a variation of RCT (Murray, 1998). The key feature of a RCT is to allocate
individuals randomly either to treatment/treatments or to a control arm (Guyatt, Rennie,
Meade, Cook, 2015). The advantages of a RCT are: 1) the design avoids conscious or
unconscious bias in selecting and allocating participants to the treatment/control arms,
and 2) attempts to balance known and unknown potential prognostic factors between the
treatment and control groups depending on the number of participants (Guyatt et al.,
2015).
In a CRT, the unit of randomization is a cluster of participants instead of individual
participants per se (Murray, 1998). The idea of cluster was introduced by researchers
from the American Bureau of the Census in the 1930s and 1940s (Cornfield, 1978). The
CRT is useful when intervention is offered at a group level, can manipulate the physical
or social environments of individuals, or is simply undeliverable to individuals (Murray,
1998). The CRT is the gold standard in public health and medicine when the allocation of
an intervention is necessary for identifiable groups (Murray, Varnell, & Blitstein, 2004).
An identifiable group refers to a non-random group of individuals sharing similar
physical, social, geographic, or other attributes (Murray et al., 2004).
The target population for our proposed CRT includes older adult residents with dementia
living in LTC homes. The residents would be considered as an identifiable group.
Randomizing the LTC homes is convenient for the administration of the VR therapy,
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requiring half the number of VR machines (each costing CAD 23000
[https://docsend.com/view/7apg24k]), half the number of intervention rooms, and half the
number of staff to maintain the VR units. Further, we acknowledge that participants
cannot be blinded if individual randomization is performed. Our VR therapy intervention
will be delivered using a projection device (i.e., MK player 3600 [The Projected VR
Company, 2019]) located in a separate room in the LTC home. There is a chance that
participants and possibly their family may notice someone experiencing VR therapy and
either request the therapy for their family member or provide something similar when
visiting (contamination). Further, because blinding of staff would not be possible, and
since staff are completing outcome measures, the risk of detection bias also would
increase.

5.2

Why matched-pair CRT?

Since a relatively small number of clusters are randomized in a CRT, an investigator is
challenged with balancing the prognostic factors between and among groups (Hayes &
Moulton, 2017). Possible ways to achieve similarity among the comparison groups are: 1)
to match their baseline characteristics, 2) to stratify similar group of clusters, and 3) to
perform an adjusted analysis of covariates (Hayes & Moulton, 2017). The general
consensus among clinical epidemiologists is to use matched-pair design when the number
of clusters in each arm is small (less than 10-15) and when closer matching is possible to
reduce between-cluster variance (Hayes & Moulton, 2017; Todd, Carpenter, Li,
Nakiyingi, Gray, & Hayes, 2003).
A sample size calculation yielded 14 clusters in each arm with convincing evidence to
adopt a matched-pair design. The PI (MS) proposes close matching of each member of
the pair based on geographic location (urban/rural), size (<100-bed/>100-bed), ownership
status (for profit/non-profit), presence/absence of a locked unit, accreditation status
(Y/N), and population served (>50% indigenous/non-indigenous community).
PI (MS) assumes that those LTC homes located in urban areas vs. those in rural and/or
remote areas likely house greater number of residents. PI (MS) anticipates that large LTC
(>100-bed) may house greater number of residents with dementia compared to small LTC
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(<100-bed). PI (MS) also anticipates that ownership and accreditation status may
influence the motivation for quality control that may impact adherence to study protocol,
thus affecting the outcome. In PI (MS) judgement, a locked unit indicates a higher
number of participants with severe dementia that may influence the outcome.

5.3

Ethical issues in CRT

The key ethical issue in any clinical trial, CRT or RCT, is to obtain informed consent
from participants, their legal guardians or SDM (Hayes & Moulton, 2017). Since CRT
randomizes clusters, individuals cannot decide separately whether or not to consent
(Hayes & Moulton, 2017). Therefore, the consenting process involves a decision maker
(gatekeeper) on behalf of the entire cluster (Hayes & Moulton, 2017). The Medical
Research Council guidelines (MRC, 2002) recommend seeking consent from a
representative of a cluster who is expected to represent the interests of cluster members
for CRT. The investigator should keep the cluster representative informed of the trial
developments. The representative is advised and made aware that he/she can withdraw
consent any time during the trial (MRC, 2002). However, a potential conflict of interest
arises when the same entity representing trial participants gets involved in trial
developments (Gallo et al., 2012). According to the Ottawa Statement on the Ethical
Design and Conduct of Cluster Randomized Trials (Weijer et al., 2012), gatekeepers
should not provide proxy consent on behalf of individuals in their cluster. The expected
role of gatekeepers with legitimate authority are to provide or to withhold permission to
enroll a cluster (Weijer et al., 2012).
The target population is LTC residents. Their 24-hour nursing care and help with daily
activities, their primary medical care, and their home environment are provided by LTC
home staff (Ontario Long-Term Care Association, 2019). Therefore, the LTC
administrative authority is selected as cluster representative for the proposed CRT. LTC
homes will be randomized after cluster representative provide permission to enroll in the
trial. Since LTC administrative authority are in the position to protect the interests of the
clusters, one LTC representative will be invited from each cluster to be a co-investigator
and to be a member of the trial steering committee following recommendations from
earlier research (Gallo et al., 2012; MRC, 2002; Weijer et al., 2012).
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As for cluster members (LTC residents), PI (MS) will follow Zelen’s method (1974) of
consent. Zelen's (1974) method involves individual participants (in this case, LTC
residents) being randomized before consenting. PI (MS) will inform the SDM of the LTC
residents who have been assigned to the intervention, the purpose and method of the trial
and will invite them to consent on behalf of the residents to participation in trial after
randomizing the clusters. However, those randomized to the control group will not be
informed that they and their LTC home are part of a trial. Instead, they will be informed
of the trial procedures. They will be invited to consent to follow-up. The reason for such
process is to avoid false hope among the cluster members that there is a novel treatment
available only to deny it through the randomization (O'Rourke et al., 1989).

5.4

Determination of Sample Size

5.4.1

Why sample size matters for CRT?

A good estimate of sample size is important in a CRT because recruiting an additional
cluster versus an additional individual is expensive (Rutterford, Copas, & Eldridge,
2015). In addition, over-or under-recruitment in CRT implies a large or small number of
individuals are being exposed unnecessarily to risks or benefits (Rutterford et al., 2015).
5.4.2

Sample size calculation for a non-cluster RCT

Since our proposed trial is investigating a novel intervention (VR therapy) and since we
will measure continuous variables, we initially considered non-cluster equality trial (no
clinically meaningful difference between the intervention and the control) with a
continuous variable to calculate the sample size (S=2xN) assuming the Type I error rate
(α) is 5%, and power (1-β) is 80% (Chow, Shao, Wang, & Lokhnygina, 2018; Lachin,
1981). N refers to number of individuals, Zα/2 refers to Type I error rate, Zβ refers to Type
II error rate, σ refers to within group variance, and δ refers to between group variance
(equation 1).
N/group = 2 (Zα/2 + Zβ)2 σ2
δ2

(1)
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Results from the pilot study (please refer to Chapter 2 of this thesis) showed that VR
therapy caused a change in CSDD score (ES= 0.4, 95% CI, 2.4 to -1.7). Therefore, the
sample size needed for a non-cluster equality trial is 216 residents (108 per group) (Kohn
et al., 2019).
5.4.3

Sample size calculation for a CRT

The variance between the clusters and the variance among the individuals within a cluster
reduces the statistical power of a CRT compared to RCT with the same sample size
(Cornfield, 1978). Donner and colleagues (1981) proposed inflating the CRT sample size
by design effect (D) to address this issue (equation 2; m=number of individuals per
cluster, ICC=Intra-cluster Correlation Coefficient).
D=1 + (m–1) × ICC

(2)

ICC is the numerical expression of the extent of similarity among the individuals within a
cluster (Donner, 1986). In case of no similarity, the value of ICC is 0 and vice versa. The
individuals within a cluster are likely to be more similar than those from different clusters
(Donner, 1986). In absence of available literature on ICC for the CSDD scale, we
estimated the ICC value (0.05) of Geriatric Depression Scale-15 (Sheikh & Yesavage,
1986) based on the work of Underwood and colleagues (2013).
One of the eligibility criteria for clusters (LTC homes) is having at least 60 beds for
people with dementia for the proposed CRT. The recruitment rate of the pilot study was
40% (please refer to Chapter 2 of this thesis). Therefore, the cluster size (m) for this CRT
is 24 residents. The sample size for CRT (SCRT) with equation 3 (Donner et al., 1981) is
464.
SCRT =SS×D

(3)

For practical purpose, PI (MS) is encouraged to aim for a larger sample size to account
for potential dropouts (attrition rate) (Chow et al., 2018). Possible reasons for dropout
may include death, transfer to another LTC/palliative care, adverse reaction to the VR
therapy, or hospitalization among other reasons. The attrition rate of the pilot was 0%
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(95%CI, 0% to-12.5%). However, the pilot study included one LTC home and the length
of intervention was only two weeks. Therefore, we considered using a surrogate attrition
rate (21%; 95% CI, 7% to 42%) from a similar study (Klages et al., 2011) to calculate a
realistic sample size. Considering the upper boundary of the 95%CI for attrition rate from
Klages and colleagues (2011), the final sample size for the proposed CRT is 659
residents or 28 LTC homes or 14 matched pairs.

5.5

Analysis scheme for CRT

PI (MS) will use intention-to-treat analysis to avoid bias in estimating the effect of VR
therapy as it compares the groups in terms of the intervention to which they were
randomly allocated, regardless of protocol deviations and participant compliance or
withdrawal (Schwartz & Lellouch, 1967).
5.5.1

Accounting for cluster effect

According to Cornfield (1978), analyzing individual data without considering cluster
effect is “an exercise of self-deception” (p.102). Observations on individuals in the same
cluster cannot be assumed independent (Hayes & Moulton, 2017). If we ignore the
clustering effect (ICC), our confidence intervals will be over-narrow, misleading our
conclusions (Campbell et al., 2000; Campbell & Grimshaw, 1998; Ukoumunne,
Gulliford, Chinn, Sterne, Burney, & Donner, 1998). Therefore, data analysis in CRT
needs to account for ICC (Donner, 1998).
5.5.2

Type of analysis

We want to know if usual care and VR therapy reduce BPSD in the target population
compared to usual care alone. We will measure BPSD of individuals with a collection of
instruments. The natural unit of inference is the individual level. Therefore, we will
account for ICC while analyzing the data (report the mean differences between the
groups in each matched pair divided by the square root of D [ D=1 + (m–1) × ICC]
[Murray, 1998; Campbell & Walters, 2014]). Since this CRT will produce longitudinal
data (collected sequentially from the same residents over time), a regression analysis is
appropriate (Der & Everitt, 2013).
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5.5.3

Type of model

PI (MS) will perform mixed model regression analysis (a statistical model containing
both fixed effects and random effects), fit for clustered data (Fitzmaurice, Laird, & Ware,
2004). In CRT, the variance within a cluster is usually less than the variance between the
clusters (Fitzmaurice et al., 2004). When using individual level continuous outcome data,
application of robust standard errors (SE) in regression models can provide a valid Type I
error (α) with an unequal variance assumption (Campbell and Walters,2014).
Robust SE=V( 1- 2)=

+

In this equation (4), V is the variance of the difference,

(4)

1

and

2

refer to mean of group

1 and 2, s21 and s22 means standard deviation of group 1 and 2, n1 and n2 are the size of
group 1 and 2.
5.5.4

Handling missing data

Missing values can lead to challenges in identifying the intention-to-treat population
(Unnebrink & Windeler, 2001). PI (MS) will evaluate whether data are missing
completely at random (MCAR), missing at random (MAR), or missing not at random
(MNAR). PI (MS) will report them in each matched pair at baseline, at the end of study,
and at follow-up with a frequency table for better understanding of missingness of data
following the work of Huntington and Dueck (2005).
MCAR does not depend on the observed or unobserved outcome (Little & Rubin, 2002).
For an example, a resident may die during the trial and his/her outcome data will be
missing. MAR data depend on variable(s) unrelated to the outcome (Little & Rubin,
2002). For an example, a resident may have an unplanned visit with family/friends during
the trial that is unrelated to his/her BPSD. MNAR, on the other hand, is related to the
outcome (Little & Rubin, 2002). For an example, a resident’s BPSD may have
improved/deteriorated during the trial and decided not to return to VR therapy.
MCAR and MAR data are likely to be rare occurrences, while MNAR data may
introduce under or over estimations of treatment effects (Bell & Fairclough, 2014).
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Several methods exist to handle missing data in clinical trials such as maximum
likelihood estimation (Fisher, 1922), propensity score matching (Rosenbaum & Rubin,
1983), complete-case analysis (Von Hippel, 2007), and imputation (single and multiple)
methods (Carpenter & Kenward, 2008; Rubin, 1987). In maximum likelihood estimation,
data are assumed to be independent and identically distributed (Kim & Shao, 2013).
Propensity score matching is typically used for trials exploring causal relationship using
large non-randomized data (Newgard, Hedges, Arthur, & Mullins, 2004). Complete-case
analysis is preferred when only outcome data are missing (van Buuren, 2018). In cases of
MAR and MNAR data, complete-case analysis performs poor and inflates Type II error
(β) rate (van Buuren, 2018). Single imputation involves replacing missing values with
observed values or replacing missing values with the last measured value (Carpenter &
Kenward, 2008). The method yields small SE because it ignores the uncertainty of
missing values (Carpenter & Kenward, 2008).
On the other hand, multiple imputation (Rubin, 1987) accounts for all uncertainty in
predicting missing values and create multiple copies of the dataset, replacing missing
values with predicted imputed values and fit the model of interest to each of the imputed
datasets to get an average estimate (Sterne et al., 2009). PI (MS) will perform multiple
imputation within clusters to obtain statistically valid inferences from missing data based
on previous research (Campbell & Walters, 2014; Ma, Raina, Beyene & Thabane, 2013;
van Buuren, 2018).
5.5.5

Cost analysis

PI (MS) recognizes that certain costs are associated with managing BPSD (a composite
variable representing a large number of conceptually related but differently
caused/initiated and manifested behaviours) and implementing this CRT. The primary
outcome of the proposed CRT is a clinical variable (BPSD) instead of a cost variable.
The sample size is calculated based on the primary outcome. Cost variables usually have
higher variance than clinical outcomes, requiring a larger sample size (Briggs & Gray,
1998).
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Considering the infancy of research related to the effects of VR therapy on the behaviours
of persons living with dementia, all categories of resources involved, unit costs of
different resources (direct and indirect) with variances, variability of resources in
between the clusters, and the maximum cost LTC homes are willing to pay for each
meaningful unit of BPSD gain (or loss depending on the valence of the behaviours) are
not known at this time. Therefore, economic evaluation (comparative analysis of costs
and consequences attached to an intervention) involving cost-effectiveness analysis, costutility analysis, cost-benefit analysis, or cost-minimization analysis is beyond the scope
of the proposed CRT. However, our simple cost comparison can display graphically
(Figure 1) the cost-consequence of VR therapy in each matched pair using Black’s twodimensional quadrants (Black, 1990), useful for someone interested to implement such
therapy to evaluate multiple strategies and to make more informed decisions.

High cost,

High cost,

reduced

not reduced

BPSD

BPSD

Low cost,

Low cost,

reduced

not reduced

BPSD

BPSD

Figure 5. Cost-consequence of VR therapy. (BPSD= Behavioural and Psychological
Symptoms of Dementia)

5.6

Directions for future research

PI (MS) expects the results of the proposed CRT will extend to LTC residents with
dementia irrespective of different types of dementia and the degree of different sensory
system impairments (e.g., hearing, vision, dual vision). However, we are uncertain, how
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the results will apply to older adults with dementia who live in their own home, are
hospitalized, or require someone to setup and to maintain the VR machine, to control the
images, and to accompany the user to avoid possible AE (e.g. falls). It is crucial to
examine these and other effects regarding the evaluation of implementing VR therapy.
Future research also can explore private homes or hospitals to see if VR therapy can
reduce BPSD at the same rate or how VR therapy can be provided.
We have gaps in our knowledge regarding the ideal exposure length, frequency and
imagery types of VR therapy. Future research should examine the optimum duration (cutoff point) of the therapy eliciting similar effect in people with different types of dementia.
Finally, PI (MS) expects to provide useful insight into the cost associated with VR
therapy implementation. However, an economic evaluation in future research can
quantify any gain in the quality of life of the older adults with dementia, individual’s/
institution’s/ society’s/policy makers’ willingness to pay to gain such benefit (if any) or
can evaluate how much health care dollars are saved using such therapy.
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Appendix E: Eligible long-term care homes (LTC) (n=158)
Name of LTC

Location
(Urban
[U]/Rural
[R]

Size (60100 bed/
>100 bed

Locked
unit
(Yes/no)

Accreditation
(Yes/no)

Serving >50%
indigenous
population
(Yes/no)

For Profit
(Yes/no)

Copper Terrace

R

>100 bed

Yes

Yes

No

Yes

Riverview
Gardens

U

>100 bed

Yes

No

No

No

Afton Park
Place

U

>100 bed

Yes

Yes

No

Yes

Extendicare
Southwood
Lakes

U

>100 bed

No

Yes

No

Yes

Extendicare
Tecumseh

U

>100 bed

No

Yes

No

Yes

Fiddick's
Nursing Home

R

60-100
bed

No

Yes

No

Yes

Royal Oak

U

>100 bed

Yes

Yes

No

Yes

The Village at
St Clair

U

>100 bed

Yes

Yes

No

Yes

The Village of
Aspen Lake

U

>100 bed

No

Yes

No

Yes

Cedarcroft
Place

R

60-100
bed

No

No

No

Yes

Arbor Trace

R

60-100
bed

No

No

No

Yes

Dearness
Home

U

>100 bed

Yes

Yes

No

No

Henley Place

U

>100 bed

Yes

Yes

No

Yes

Kensington
Village

U

>100 bed

No

Yes

No

Yes

McCormick
Home

U

>100 bed

Yes

Yes

No

Yes

Meadow Park

U

>100 bed

No

Yes

No

Yes

Queens Village

R

60-100
bed

Yes

No

No

Yes

Spruce Lodge

R

>100 bed

Yes

Yes

No

No

Mount Hope

U

>100 bed

Yes

Yes

No

No
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Centre
Strathmere
Lodge

R

>100 bed

Yes

Yes

No

No

Village of
Glendale
Crossing

U

>100 bed

Yes

Yes

No

Yes

Woodingford
Lodge

U

>100 bed

Yes

Yes

No

No

People Care
AR Goudie

R

60-100
bed

Yes

No

No

Yes

Caressant Care

R

60-100
bed

No

Yes

No

Yes

Cambridge
country manor

R

60-100
bed

No

Yes

No

Yes

Caressant care

R

60-100
bed

No

Yes

No

Yes

Revera
Columbia
Forest

U

>100 bed

No

Yes

No

Yes

Village of
Riverside Glen

U

>100 bed

No

Yes

No

Yes

Arbour Creek

U

>100 bed

Yes

No

No

Yes

Burloak

U

>100 bed

Yes

Yes

No

Yes

Bella Care
Residence

U

>100 bed

Yes

Yes

No

Yes

Grandview
Lodge

U

>100 bed

Yes

Yes

No

No

Heritage Green

U

>100 bed

Yes

Yes

No

No

Linhaven

U

>100 bed

Yes

Yes

No

No

Maple Park
Lodge

R

60-100
bed

Yes

Yes

No

Yes

Norview
Lodge

R

>100 bed

Yes

Yes

No

No

Ridgeview

R

>100 bed

Yes

Yes

No

Yes

St Peter's
Residence

U

>100 bed

Yes

Yes

No

Yes

The Village of
Wentworth
Heights

U

>100 bed

Yes

Yes

No

Yes

The Village of
Tansley Woods

U

>100 bed

Yes

Yes

No

Yes
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Burton Manor

U

>100 bed

No

Yes

No

Yes

Deerwood
Creek Care

U

>100 bed

No

Yes

No

Yes

Dufferin Oaks

U

>100 bed

No

Yes

No

No

Faith Manor

U

>100 bed

No

Yes

No

No

Hawthorn
Woods

U

>100 bed

No

Yes

No

Yes

King Nursing
Home

R

60-100
bed

Yes

Yes

No

Yes

Kipling Acres

U

>100 bed

No

Yes

No

No

Malton Village

U

>100 bed

No

Yes

No

No

Maple Grove

U

>100 bed

No

Yes

No

Yes

Tall Pines

U

>100 bed

No

Yes

No

No

Village of
Sandalwood
Park

U

>100 bed

No

Yes

No

Yes

Copernicus
Lodge

U

>100 bed

Yes

Yes

No

No

Fountain View

U

>100 bed

Yes

Yes

No

Yes

Ivan Franko
Home

R

60-100
bed

Yes

Yes

No

No

Lakeshore
Lodge

U

>100 bed

Yes

Yes

No

No

True Davidson
Acres

U

>100 bed

Yes

Yes

No

No

Cawthra
Gardens

U

>100 bed

Yes

Yes

No

Yes

Cooksville
Care

U

>100 bed

No

Yes

No

Yes

Dom Lipa

R

60-100
bed

No

No

No

No

Extendicare
Mississauga

U

>100 bed

No

Yes

No

Yes

The Village of
Erin Meadows

U

>100 bed

Yes

Yes

No

Yes

Sheridan Villa

U

>100 bed

Yes

Yes

No

No

Camilla Care

U

>100 bed

Yes

Yes

No

Yes

Silverthorn
Care

U

>100 bed

No

Yes

No

Yes

Streetsville

U

>100 bed

No

Yes

No

Yes
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Care
Villa Forum

U

>100 bed

No

Yes

No

Yes

Waterford

U

>100 bed

Yes

Yes

No

Yes

Wenleigh

U

>100 bed

Yes

Yes

No

Yes

West Oak
Village

U

>100 bed

Yes

Yes

No

Yes

Westbury

U

>100 bed

No

Yes

No

Yes

Apotex Centre

U

>100 bed

Yes

Yes

No

No

Belmont House

U

>100 bed

Yes

Yes

No

No

Castleview
Wychwood
Towers

U

>100 bed

Yes

Yes

No

No

Cedarvale
Terrace

U

>100 bed

Yes

Yes

No

Yes

Chester Village

U

>100 bed

Yes

Yes

No

No

Fudger House

U

>100 bed

Yes

Yes

No

No

Harmony Hills

U

>100 bed

Yes

Yes

No

Yes

Hellenic Home
for the Aged

R

60-100
bed

Yes

Yes

No

No

Heritage

U

>100 bed

Yes

Yes

No

Yes

Kensington
Gardens

U

>100 bed

Yes

Yes

No

No

Mon Sheong
Foundation

U

>100 bed

Yes

Yes

No

No

Rose of Sharon

R

60-100
bed

Yes

Yes

No

No

Isabel and
Arthur
Meighen
Manor

U

>100 bed

Yes

Yes

No

No

True Davidson
Acres

U

>100 bed

Yes

Yes

No

No

Houses of
Providence

U

>100 bed

Yes

Yes

No

No

Vermont
Square

U

>100 bed

Yes

Yes

No

Yes

West Park

U

>100 bed

Yes

Yes

No

No

Bloomington
Cove Care

R

>100 bed

No

Yes

No

Yes

River Glen

R

>100 bed

No

Yes

No

Yes
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Haven
Newmarket
Health Centre

R

>100 bed

No

Yes

No

No

Arbour Heights

U

>100 bed

Yes

Yes

No

Yes

Crown Ridge
Place

R

>100 bed

Yes

Yes

No

Yes

Fairmount
Home

R

>100 bed

Yes

Yes

No

No

Hallowell
House

R

60-100
bed

Yes

Yes

No

Yes

Hastings
Centennial
Manor

R

>100 bed

Yes

Yes

No

No

Hastings
Manor

U

>100 bed

Yes

Yes

No

No

Helen
Henderson
Care Centre

R

>100 bed

Yes

Yes

No

Yes

HJ McFarland
Memorial
Home

R

60-100
bed

Yes

Yes

No

No

John M Parrott
Centre

R

>100 bed

Yes

Yes

No

No

Lanark Lodge

R

>100 bed

Yes

Yes

No

No

Moira Place

R

>100 bed

Yes

Yes

No

Yes

Providence
Manor

U

>100 bed

Yes

Yes

No

No

Rideaucrest
Home

U

>100 bed

Yes

Yes

No

No

St Lawrence
Lodge

U

>100 bed

Yes

Yes

No

No

Stirling Manor

R

60-100
bed

No

No

No

Yes

Trillium

U

>100 bed

Yes

Yes

No

Yes

Westgate
Lodge

U

60-100
bed

Yes

Yes

No

Yes

Carlingview
Manor

U

>100 bed

Yes

Yes

No

Yes

Marianhill

U

>100 bed

Yes

Yes

No

No

Fairvern

R

60-100
bed

No

Yes

No

No
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Georgian
Manor

R

>100 bed

Yes

Yes

No

No

Grove Park
Home

U

>100 bed

Yes

Yes

No

No

Hillcrest
Village

R

>100 bed

Yes

Yes

No

Yes

Leacock

U

>100 bed

Yes

Yes

No

Yes

Muskoka
Landing

R

60-100
bed

No

Yes

No

Yes

Pines

R

>100 bed

Yes

Yes

No

No

Roberta Place

U

>100 bed

No

Yes

No

Yes

Muskoka
Shores Care

R

>100 bed

Yes

Yes

No

Yes

Sunset Manor

R

>100 bed

No

Yes

No

No

Spencer House

U

>100 bed

No

Yes

No

Yes

Trillium Manor

U

>100 bed

Yes

Yes

No

No

Victoria
Village Manor

U

>100 bed

Yes

Yes

No

No

Woods Park
Care Centre

U

>100 bed

Yes

Yes

No

Yes

Nipissing
Manor

R

>100 bed

No

Yes

Yes

Yes

Algoma Manor

R

60-100
bed

Yes

Yes

Yes

No

Algonquin
Nursing Home

R

60-100
bed

No

Yes

Yes

No

Au Chateau -

R

>100 bed

No

Yes

Yes

No

Belvedere
Heights

R

>100 bed

Yes

Yes

Yes

No

Cassellholme

U

>100 bed

No

Yes

Yes

Yes

Eastholme

R

>100 bed

No

Yes

Yes

No

Elizabeth
Centre

R

>100 bed

No

Yes

Yes

Yes

Espanola
Nursing Home

R

60-100
bed

Yes

Yes

Yes

No

Falconbridge

U

>100 bed

Yes

Yes

Yes

Yes

Kirkland Lake

R

60-100
bed

No

Yes

Yes

Yes

Maple View

U

>100 bed

Yes

Yes

Yes

Yes
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Extendicare Timmins

U

>100 bed

Yes

Yes

Yes

Yes

Extendicare Van Daele

U

>100 bed

Yes

Yes

Yes

Yes

Extendicare
York

U

>100 bed

No

Yes

Yes

Yes

F J Davey
Home

U

>100 bed

Yes

Yes

Yes

No

Hoivakoti

U

>100 bed

No

Yes

Yes

Yes

Golden Manor

U

>100 bed

Yes

Yes

Yes

No

Lakeland

R

>100 bed

Yes

Yes

Yes

No

North
Centennial
Manor

R

60-100
bed

Yes

Yes

Yes

Yes

Pioneer Manor

U

>100 bed

Yes

Yes

Yes

No

St Joseph's
Villa

U

>100 bed

Yes

Yes

Yes

No

Villa St
Gabriel

R

>100 bed

Yes

Yes

Yes

No

Water’s Edge

U

>100 bed

Yes

Yes

Yes

Yes

Princess Court

U

60-100
bed

Yes

Yes

Yes

No

Pinecrest
Home

U

>100 bed

Yes

Yes

Yes

No

Rainycrest

R

>100 bed

Yes

Yes

Yes

No

Southbridge
Care Homes

U

>100 bed

Yes

Yes

Yes

Yes

Birchwood
Terrace

U

60-100
bed

Yes

Yes

Yes

Yes

Southbridge
Pinewood

U

>100 bed

Yes

Yes

Yes

Yes

Southbridge
Roseview

U

>100 bed

Yes

Yes

Yes

Yes

Hogarth
Riverview
Manor

U

>100 bed

Yes

Yes

Yes

No

Bethammi
Nursing Home

U

>100 bed

No

Yes

Yes

No

Pioneer Ridge

U

>100 bed

No

Yes

Yes

No
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